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Summary
The objective of this project is to increase the yield and the quality of in vitro refolded 
proteins over-expressed in E. coli as insoluble inclusion bodies by optimising the 
refolding conditions. Therefore, protein refolding additives and regimes like (Glycerol, 
Gnd-HCl, Dilution, Temperature, and Triton X-100) were investigated to determine 
their effect on tackling the problems that initiate aggregation in refolding media.
The study identified Glycerol as an unsuitable aid in the refolding of Con A due to the 
binding effect it possessed towards the affinity dextran. Moreover, recommended the 
use of 0.5 M Gnd-HCl concentration as the initial point that guarantee suitable refolding 
yields. The rapid and continuous dilution protocols were proved to be more suitable 
than the other exploited refolding techniques in improving the refolding yields of Con 
A. However, rapid dilution was the preferable method to use since it is simple and 
reproducible. The 30X dilution factor was considered the optimum to enhance the 
refolding yields.
A gradual warm up step with 2 hours ice incubation period instead of 1 hour combined 
with the above mentioned technique ensured the recovery of most of the refolded Con 
A. Triton X-100 was unsuitable to aid the refolding of Con A due to its inhibitory 
effects on essential hydrophobic associations. However, its use as a tool was considered 
a breakthrough for estimating the time-course of refolding of the lectin.
Following the resultant optimised strategy the renaturation yield was improved in our 
laboratory from a mere 12 to 33 mg/1 culture i.e. a 2.75-fold increase, providing that 
more detailed experiments are conducted to improve the use of Triton X-100 as a tool 
method using purified proteins with accurately known concentration values.
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Chapter One
General Introduction
1.1 Expression System
1.1.1 Introduction
The production of pharmaceutical proteins through the expression of cloned genes in 
prokaryotic cells is widely exploited both in industry and research (Clark, 1998). The 
production of recombinant proteins depends on: expression levels, cell growth 
characteristics, post-translational modifications, and biological activity of the protein 
under investigation. The metabolic functions of the cell have to be controlled in a very 
precise manner because of the need to coordinate their activities, and to prevent the 
wasteful synthesis of unnecessary materials, or the accumulation of toxic products. This 
control is achieved at two main levels: regulation of the level of production of specific 
enzymes, and control of the activity of those enzymes. The activity of an enzyme, which 
essentially means its affinity for a specific substrate and the rate at which it carries out 
the reaction, is genetically determined by its structure, as well as being influenced by 
the surrounding conditions. The susceptibility of an enzyme to feed back inhibition (or 
activation), and other properties such as temperature stability, are also determined by its 
structure.
Analysis of how the informational events accelerates from the structure of a gene to the 
activity of the enzyme as the final product; reported a series of factors that can mark the 
overall regulation of that activity (Dale and Park, 2004). In summary, these are:
1-The number of copies of the gene:
The level of product depends on the number of copies.
2-The efficiency with which the gene is transcribed:
Many factors affect the amount of mRNA and the initiation of transcription by RNA 
polymerase is playing a leading role in that. 
a-The stability of wRNA:
The rate of production and the length of time each molecule exists in an active state in 
the cell are important effectors in determining the amount of specific raRNA. Most 
bacterial raRNA persists in a timid time, with a half-life of about 2 minutes. One of the 
important features in the bacterial adaptation to changes in their environments is due to 
the stability of bacterial mRNA, although, some bacterial mRNA species are more stable 
than others. The mRNA encoded by some bacteriophages is clearly more stable than is 
usual in bacterial cells. Other forms of RNA (rRNA, /RNA) are also to some extent
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more stable, which can be related to the high degree of secondary structure owned by 
these molecules.
b- The efficiency with which the raRNA is translated into protein:
This will be influenced by the efficiency of inhibition, and also by factors that affect the 
rate at which the ribosome travel along the mRNA. 
c- The stability of the protein product:
As with the wRNA, the amount of protein indicates both its rate of production and its 
stability. Different proteins varying their stability to a noticeable degree, as might be 
expected from their different functions: a protein that forms part of a cellular structure is 
likely to be more stable than one that transmits a signal for switching on a transient 
cellular event, 
d- Post-translational effects:
This consists of a series of events such as protein folding which is necessary for 
conversion of polypeptide chains into biologically active forms of structure, as well as 
covalent modifications that can affect the activity of the protein. Phosphorylation is 
especially important as a mechanism for regulating the activity of specific proteins.
1.1.2 Escherichia Coli
In the present study mature Concanavalin A is being expressed in Escerichia coli 
because of its many advantages as a valuable host according to (Hannig and Makrides, 
1998; Makrides, 1996; and Goeddel and Gold, 1990). Therefore, a brief description of 
the organism and its characteristic is vital to enlighten the role it played in this part of 
the project. E. coli a gram-negative, non-pathogenic, short, motile, rod-shaped organism 
always < 1 micrometer in length present naturally as an intestinal fauna organism that is 
not normally available in water or soil. The organism has a high capability of 
multiplication which enabled it to be the favourite choice when considering laboratory 
research. Simple culture media containing ions like (Na+, K+, Mg2+, Ca2+, N H /, Cf,
9 9HPO4 ', and SO4 '), trace elements and glucose are the best attributes for good E. coli 
growth production. The logarithmic phase of E. coli growth rate is about 22 minutes at 
an incubation temperature of 37°C. The microorganism is a non selective bacterium 
that can be grown either aerobically or anaerobically, although, the optimal production 
always occurred aerobically. The production of recombinant proteins using E. coli as a 
host require specific complex media that is rich in amino acids, vitamins, salts, trace
3
elements, and glucose. Moreover, special equipment like certain shaped flasks that can 
allow for maximum aeration and also shaking incubators at optimum temperatures are 
essential parts in the large scale production of recombinant proteins. E. coli is the most 
frequently used prokaryotic expression system for the high-level production of 
heterologus proteins. However, despite its many advantages, the efficient expression of 
different genes in E. coli wasn’t a routine matter, as the structural features of different 
genes and their transcribed wRNAs preclude the adoption of a generally applicable 
expression method.
1.1.3 Essential Components of Expression Vectors
Hanning and Makrides (1998) described the prokaryotic expression vector as a set of 
homogeneous genetic factors that influence both transcriptional and translational 
aspects of protein production. Furthermore, the vector copy number is dictated by the 
origin of replication (on) and the selected vector through the inclusion of antibiotic- 
resistance gene.
1.1.3.1 Gene Copy Number
Most genes on the bacterial chromosome are present as single copies (with a few 
notable exceptions such as the genes for rRNA and for many of the specific /RNA 
species); gene copy number is not therefore an important method of control for most of 
the normal metabolic activities of a bacterial cell. However, it becomes important, when 
consider plasmid-mediated characteristics, particularly with reference to the cloning and 
expression of heterologus DNA. Some plasmids are present within the cell in very high 
numbers (running to thousands of copies), and this is reflected in enhanced level of 
expression of the genes they carry.
1.1.3.2 Transcriptional Control
1.1.3.2.1 Promoter
The promoter is a site on DNA to which RNA polymerase can bind and begin 
transcription. It is composed of a hexa-nucleotide sequence that is positioned 
approximately 35bp upstream of the transcription initiation base separated by a short 
spacer from another hexa-nucleotide sequence. Different types of promoters can affect
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the expression of genes in E. coli; therefore, selection of the suitable promoter depends 
according to Goldstein and Doi (1995) and Yansura and Henner (1990), on; The 
promoter strength where it should be able to produce more thanl0-30% of the total 
cellular protein as expressed protein, and represent the minimum level of basal 
transcription. Promoters should be able to produce a noticeable effect in a 
straightforward and inexpensive way where they are used as thermal or chemical 
inducers. Isopropyl-B-D-thiogalactopyranoside (IPTG) is an example of effective 
inducers of the powerful hybrid lac (De Boer et al.,1983) and trc (Brosius et al., 1985) 
promoters although their usage in industry is quite restricted because of high costs and 
toxicity.
1.1.3.3 Transcriptional Terminator
A promoter during transcription can terminate its function, unless a transcription 
terminator is placed up-stream of the promoter, moreover, this transcription terminator 
as indicated by (Nishihara et al., 1994) when present up-stream has a negative effect on 
background transcription. Continued transcription from strong promoters into the 
replication region can destabilize plasmids, owing to overproduction of the recombinant 
protein, which involved in the control of plasmid copy number. In addition, 
transcription terminators enhance mRNA stability and can substantially increase the 
level of protein production as reported by Hayashi and Hayashi (1985).
1.1.4 Protein Synthesis
The translation of the mRNA proceeds near its 5' terminal with the formation of the 
corresponding amino terminal of the protein molecule. The message is read from 5' to 
3', concluding with the formation of the carboxyl terminal of the protein. Again the 
concept of polarity is apparent. The transcription of a gene into the corresponding 
mRNA or its precursor first forms the 5' terminal of the mRNA molecule. In 
prokaryotes, this allows for the beginning of mRNA translation before the transcription 
of the gene is completed. In eukaryotic organisms, the process of transcription is a 
nuclear one; mRNA translation occurs in the cytoplasm. This precludes simultaneous 
transcription and translation in eukaryotic organisms and makes possible the processing 
necessary to generate mature mRNA from the primary transcript-/?RNA.
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1.1.4.1 Translational initiation
Environment of ribosome binding site (RBS) sequence with adenine and thymidine 
residues, the mutation of specific residues and the use of translationally coupled 
systems, are procedures that have been improved to minimize the initiation for 
secondary formation at the 5'end of the transcript. In addition, the optimised 
characteristics at the 5'end of the mRNA transcript are known as the main factors in 
providing an efficient way of mRNA translational initiation, (Makride, 1996).
1.1.4.2 Translational enhancers
Translational enhancers are sequence components from E. coli and bacteriophages 
include: a sequence from the 77-phage gene-10 leader; U-rich regions in the 5' 
untranslated region (UTR) of certain mRNA, such as the E. coli at pET gene; and the 
'down stream box' located directly down stream of the start codon in T7 genes. Little is 
known about their mode of action as these sequences do not function as universal 
translational enhancers in E. coli (Andrews et al., 1996).
1.1.4.3 Translational terminators
mRNA translation is terminated by stop codons and E. coli expression vectors usually 
contain all three stop codons that stop the ribosome ’skipping’. E. coli represents a 
sensitive system towards the UAA codon; however, the translational-termination 
efficiency is more developed in the context of the tetra- nucleotide UAAU (Poole et al.,
1995).
1.1.5 THE pET System
The pET System is designed as a strong, potent scheme especially developed for the 
cloning and expression of recombinant proteins in E. coli (Figure 1.1). Selected genes 
are cloned in pET plasmids under the influence of strong bacteriophage T7 transcription 
and (optionally) translation signals; expression is initiated by offering a source of T7 
RNA polymerase to the host cell which is very sensitive and active that, when fully
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induced, almost all of the cell’s resources are converted into the selected gene 
expression; more than 50% of the total cell protein qualify for the product of interest in 
a few hours after induction. Although this system is extremely powerful, it is also 
possible to decrease the concentration of effectors for a more refined expression level. 
Decreasing the expression level can lead to improvement of the soluble yield of some 
selected proteins. Another vital advantage of this system is its ability to obtain the 
selected genes transcriptionally silent in the un-induced state. Selected genes are 
initially cloned using hosts that do not contain the T7 RNA polymerase gene, therefore, 
avoid plasmid instability due to the production of proteins that are potentially toxic to 
the host cell. The expression of the selected genes present in a non-expression host, 
might be facilitated either by infecting the host with A.CE6, a phage that carries the T7 
RNA polymerase gene under the control of the Xp and p\ promoters, or by transferring 
the plasmid into an expression host containing a chromosomal copy of the T7 RNA 
polymerase gene under lac\JV5 control. The latter case, expression is initiated by the 
addition of IPTG to the bacterial culture. Although in some cases (e.g., with innocuous 
target proteins) it may be possible to clone directly into expression hosts, though this is 
not recommended as a general approach. Two types of T7 promoter and several hosts 
that differ in their potency of inhibiting basal expression levels are available, providing 
great flexibility and the ability to optimise the expression of different types of selected 
genes.
The pET vectors were originally described by (Studier and Moffatt, 1986; Rosenberg et 
al., 1987; Studier et al., 1990). The newest pET vectors developed at Novagen offer 
improved characteristics that allow for easier cloning, identification, and purification of 
the selected proteins.
Transcription vectors: are designed for expression of the selected genes that already 
carry their own prokaryotic ribosome binding site and AUG start codon, therefore, the 
transcription vector pET-26(+) is used in the present project.
Translation vectors: composed of the highly efficient ribosome binding site from the 
phage T7 major capsid protein and used for the expression of selected genes without 
their own ribosomal binding site. The selective markers amp (ampicillin resistance) and 
Kan (kanamycin resistance) are available with the pET vectors. Both types of selection 
are widely exploited, but specific guidelines should be followed when using vectors 
carrying the p -lactamase gene. While ampicillin resistance is commonly used for 
selection in different cloning vectors, kanamycin resistance may be favoured under
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certain conditions, such as: protein expression in laboratories requiring GMP standards 
and sub-cloning target genes from other ampicillin-resistant vectors. Ampicillin 
selection diminishes in cultures because secreted p -lactamase and the low pH that 
accompanies bacterial fermentation both degrade the drug. Practical schemes to 
overcome the loss of drug resistance are to replace the medium with fresh ampicillin- 
containing media or to use the related drug, carbenicillin, which is less sensitive to low 
pH in the absence of a source of T7 RNA polymerase. Background expression is 
minimized with the lack of T7 RNA polymerase because the host RNA polymerases do 
not develop from T7 promoters and the cloning sites in pET plasmids are in regions 
that are weakly transcribed (if at all) by read-through activity of bacterial RNA 
polymerase. Preferred bacterial hosts for cloning include the E. coli K12 strains Nova 
Blue, JM109, and DH5. These strains are perfect hosts for the start of cloning of target 
DNA into pET vectors and for developing plasmids because they are recA-  endA- and 
have powerful transformation competence and good plasmid recovery yields. Nova 
Blue has the additional advantage of having a selectable F factor that allows helper 
phage infection and therefore the production of single stranded plasmid DNA for 
mutagenesis purposes. As for protein production, a recombinant plasmid is induced in 
an E. coli strain containing a chromosomal copy of the gene for T7 RNA polymerase. 
These hosts are lysogens of bacteriophage ADE3, a lambda derivative that has the 
immunity region of phage 21 and carries a DNA fragment containing the lacl gene, the 
lacUV5 promoter, and the gene for T7 RNA polymerase (Studier and Moffatt 1986; 
Novy and Morris, 2001). This fragment is inserted into the int gene, preventing ADE3 
from integrating into or cutting from the chromosome without a helper phage. Once a 
>X)E3 lysogen is formed, the only promoter known to lead transcription of the T7 RNA 
polymerase gene is the lacUV5 promoter, which is inducible by isopropyl-b -D- 
thiogalactopyranoside (IPTG). Addition of IPTG to a growing culture of the lysogen 
initiates the T7 RNA polymerase production, which in turn transcribes the target DNA 
in the plasmid.
lac o
lac promoter
lac o
T7 prom oter
T7 RNA 
polymerase
IPTG Induction 
▼
T7 RNA polymerase
INACTIVE
^7
T7 lysosyme
T7 lysozyme 
gene
lac
repressor
Target gene
0
lac
repressor
lac I gene
IPTG Induction
E. coli RNA 
polym erase
E. coli genome
F ig u r e d  Control elem ents o f the pET system
Showing the control elem ents o f  the pET system  using E. coli as a chosen host where cloning starts in a 
non-expression host that does not contain T7 RNA polym erase gene
(Left side) and transferred into expression hosts containing a chrom osom al copy o f  T7 RNA polym erase 
gene under lac UV5 control where expression induced by IPTG (right side)(Reproduced from Novagen  
(2002-2003) Catalogue).
Novagen pET system Tutorial. P84-91.
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The pET 26(+) (Figure 2.1) used in the current project as the parent expression system 
for Concanavalin A and bacterial ompA signal was used in all constructs to direct the 
products to the periplasm of E. coli. The ompA signal derived from the pIN system was 
therefore continually used as it resulted in authentic N-termini of purified Con A before 
than the pelB originally provided in pET 26b (+) (Hanning and Makrides, 1998)).
1.2 Protein Folding
1.2.1 Introduction
Protein folding poses a puzzling question in science and technology and scientists in 
research and industry are facing many challenges to unmask the mysteries that surround 
it. Not all proteins can fold spontaneously or by random search through stable 
intermediates; therefore, it is clear that folding is a more complicated process that needs 
urgent attention. Although, scientists like Jaenicke and Rudolph, 1989; Creighton, 1994; 
Radford, 2000); have tried to predict the three-dimensional structure of a protein from 
its amino-acid sequence, more studies should be conducted until an answer can be found 
to that big question. Previously Levinthal explored the possibility of randomly 
calculating the number of the different conformations that arise from the denatured state 
of a protein and the results were largely disappointing since it appeared to be a time 
consuming task. This enormous difference between the calculated and the actual folding 
time is termed Levinthal’s Paradox (Levinthal, 1968; Karplus, 1997).Proteins exist in 
marginal stability due to the difference in the free energy between the folded and 
unfolded states which can reach up to lOKcal/mol where the average stabilization 
energy calculated for a 100-residue protein is only O.IKcal/mol and that is less than 
random thermal energy (RT=0.6Kcal/mol at room temperature). Most small proteins 
can be reversibly unfolded by raising the temperature or by adding a denaturing agent 
such as H+, urea, or guanidine hydrochloride. Two conformational states are present in 
appreciable amounts a native state N (well-defined compact conformation) and unfolded 
or denatured state U (distorted or disordered) and they are in rapid equilibrium:
10
Thus, at the mid-point of the thermal or denatured states half the molecules are fully 
unfolded and the other half is fully recovered in native state. As known from Anfinsen, 
(1973); proteins are linear polypeptides that fold into active conformations depending 
on their primary structure, Levinthal, (1968); indicated that the folding process is not a 
simple but a complex issue since folding is a stepwise process. Other proteins exhibit an 
additional state which occurs under certain conditions that are represented by nearly the 
same secondary structure as the native protein described by Far Ultra-violet Circular 
Dichroism Spectra (CDS) hence: CDS distinguishes between a helix, p sheet, and 
random coil structures. By contrast, the Near Ultra-violet CDS showed that many of the 
interactions of aromatic side chains were disrupted by acid treatments, and that the 
presence of a compact molecule is evident when the denaturing acids are used in low 
concentrations, this molecule is termed the molten globule. Moreover, other scientists 
have argued the presence of this intermediate illustrating that the denatured state cannot 
directly fold into the active form without collapsing into a form of an intermediate. The 
appearance of the molten globule is now a well documented area of research and our 
knowledge of it is dictated as compact polypeptides which are composed of the native 
secondary but not the tertiary structure. Molten globule formation is driven by the 
formation of helical stretches of the secondary structure. Many short peptides in water 
possess considerable helix- forming potential. The non-polar interior of molten globule 
stabilizes nascent helices by shielding their main- chain amides and carbonyl groups 
from competing with the water molecules, hence, states like dry, wet, and swollen 
molten globule have been observed relating the presence of water molecules and their 
interactions with the polypeptide chains (Pititsyn et al., 1995b; Peng and Kim, 1994; 
Redfield et al., 1994). Also many helices contain hydrophobic phases; the presence of 
these residues within the core of the molten globule also promotes helix formation. Thus 
hydrophobic collapse and acquisition of stable secondary structure are mutually 
reinforcing events in the formation of molten globules
Proteins can be denatured when subjected to unfavourable conditions that change their 
compact folded structure by distorting the native active conformation. Examples like 
chemical denaturants, thermal induction, acidic or alkaline media, and high pressure
U MG N
stand as affecting factors in the folding process. As a result, when a protein is under 
suitable refolding conditions the molten globule appeared to be the first intermediate 
before the foundation of the fully folded native state, so Creighton (1997); postulated 
that the presence of MG is important for the protein to reach the fully folded native 
structure, but at the same time it has no role in enhancing or affecting the rapidity of the 
folding process.
The current work involves native proteins which are over-expressed in a bacterial host 
as inclusion bodies, subjected to denaturating agents, to reveal the optimum conditions 
for their refolding into native biologically active proteins. The following sections 
discuss in details: the inclusion bodies and the factors that might prevent the correct 
folding or mis- folding (aggregation).
1.2.2 Inclusion Bodies
1.2.2.1 Introduction
The production of inclusion bodies is the first part towards the accomplishment of a 
refolding process; therefore, over- expression of recombinant proteins extensively used 
recently is considered a major breakthrough in research and industry. Different system 
hosts either prokaryotes or eukaryotes are widely exploited, however, the most 
commonly explored ones are E. coli and yeast. The accumulation of recombinant 
proteins as cellular aggregates either in the cytoplasm or the periplasm of the host cell is 
known scientifically as the inclusion body formation. Inclusion bodies (IBs) are 
insoluble compounds that are, seen until recently as particles devoid of biological 
activity that upon purification IBs can give rise to active soluble proteins that are used 
extensively in many therapeutic areas. IBs can be solubilised through the use of 
chaotrops in high concentrations; denaturants like guanidine hydrochloride and urea are 
usually used with the aid of reducing agents such as a-mercaptoethanol to facilitate the 
solubilisation of IBs. Although, the use of these denaturants in high concentrations leads 
to random coil formation and exposure of the hydrophobic surfaces which are the main 
reasons of aggregation and, hence, loss of bioactivity (Singh and Panda (2005), the 
challenge is to gain bioactivity back from these inert particles, since IBs formation from 
cloned genes products is attributed to generation of an incorrectly transcribed or 
translated sequence or to secondary damage (Carrio and Villaverde (2002).
12
Solubilisation and purification of these IBs through suitable refolding techniques are the 
best sources for the optimum recovery of active proteins; moreover, the high levels of 
expression in E. coli can also be rated as one of the reasons that can add to the high 
levels of bioactive recovery. Certain advantages were achieved through IBs formation;
(i) increased purity, (ii) effortless isolation (iii) less degradation of the expressed 
protein, (iv) added protection from proteolytic degradation, and (v) homogenised 
protein (with less contaminant). Furthermore, the work of Ventura and Villaverde 
(2006); about the protein quality of bacterial IBs indicated that they are transient 
reservoirs of aggregated polypeptides which can refold back into active protein under 
favourable cellular conditions. In the following parts of this section the various aspects 
of the IBs properties and their isolation, purification and solubilisation are identified.
1.2.2.2 Properties of Inclusion Bodies
Over-expression of recombinant proteins in a cellular host like E. coli or Yeast is the 
major reason for their accumulation as inclusion bodies. Inclusion bodies are described 
morphologically as refractile dense mis-folded or disordered polypeptide chains, located 
in the cytoplasm or the periplasm of the selected host. They are known as amorphous 
structures that can be seen using light microscopy (Georgiou et al. (1986); Bowden and 
Georgiou (1990); Baneyex (1999), and Georgiou and Valax (1999). Inclusion bodies 
differ in their sizes which can reach up to several pg; in addition they consist of more 
than 50% of the total cell protein in the form of recombinant protein deposits. 
Secondary structures of polypeptide chains and contaminants of outer membrane 
proteins are the principle aggregates that form those inclusion bodies (Reddy et al. 
(1998). Washing with detergents is one of the means to eliminate the membrane 
proteins from the inclusion bodies. Practical considerations to isolate the IBs from the 
surrounding contaminants in the form of mechanical methods as high pressure 
homogenisation, chemical, enzymatic treatments or a mixture of these methods together 
are used to disrupt inclusion bodies. The resultant disrupted IBs then subjected to low 
speed centrifugation for a specific period of time or filtrated to remove the soluble 
fraction of the protein from the insoluble one. Washing by EDTA, and low 
concentrations of denaturants and/or weak detergents such as Triton X-100 (see section 
2.4.3), deoxycholate and octylglucoside (Georgiou and Valax (1999); De Bemardez
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Clark et al. (1999); Batas et al. (1999); Muller and Rinas (1999); Huxtable et al. (1998); 
Fahey et al. (2000); Lee et al.(2000); Collins et al. (1999) is widely accepted to remove 
the stubborn membrane protein and available contaminants. Moreover, there are 
ongoing studies to reveal which of these methods are the most suitable for the isolation 
of the IBs scientists like Batas et al. (1999); reported that the size of the membrane pore 
is considered as an important aspect in achieving greater protein purity as this has led to 
the observation indicating that centrifugation takes advantage of the density differences 
between cell debris and inclusion bodies. Solubilisation is another way in the 
purification of IBs maintained by different methods generally used in research or 
industry. Many preferred methods of chemical and physical treatments like the use of 
denaturants, detergents or pH and pressure are accurately selected to guarantee efficient 
refolding yield. In the next section a brief discussion of some of these treatments will 
follow:
(1) Denaturant
Denaturing is considered the best way to solubilise the IBs, although this may 
completely or partially disrupt the protein structure, the method is extensively used. 
Solubilisation may be accomplished by the complete disruption of the protein structure 
(unfolding) or by the disruption of intermolecular interactions with partial unfolding of 
the protein. Minimum amounts of the denaturant are required to unfold a protein so the 
knowledge about the protein structure and the suitability of the denaturant is vital. The 
most commonly used denaturants are guanidine hydrochloride and urea. Plenty of the 
documented literature reported the use of relatively high denaturant (6-8 M) and protein 
(1-10 mg/ml) concentrations in the solubilisation step (De Bemardez Clark 2001). 
Guanidine hydrochloride is the current solubilizing agent used extensively in our 
laboratory (see section 2.4.4) due to its stability when compared to urea that 
decomposes to cyanate and ammonia as identified by Shirley (1995), and Pace et al. 
(1989). Special precautions must be taken when urea is used for inclusion body 
solubilisation, like addition of scavengers containing free amino groups to the 
solubilisation mixture to remove any cyanate which would otherwise react with the 
protein. Moreover, other denaturants may be used like the cationic surfactant 
cetyltrimethylammonium chloride (CTAC) Rudolf and Lilie (1996).
(2) Detergents
Detergents are widely used in the washing step to remove impurities so as to prevent 
further proteolytic degradation of the IBs protein (Georgiou and Valax 1999).
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Moreover, they are also considered as solubilizing agents for the IBs. Extensively 
explored detergents are sodium dodecyl sulfate (SDS) and n-cetyl trimethylammonium 
bromide (CTAB) (De Bemardez Clark 2001). Since the use of detergents is not 
recommended in solubilisation as they may interact with the chromatographic 
procedure, the removal of these agents is important to achieve a suitable refolding yield. 
Cyclodextrins, linear dextrins or cycloamylose are compounds that can interfere with 
the detergent chemical structure by forming a mixture that can be removed from the 
refolding environment. During this project TritonX-100 is used in the washing step to 
purify ConA inclusion pellets (see section 2.4.6).
(3) (Reducing agents)
Such as dithiothreitol (DTT), dithioerythritol (DTE), and 2-mercaptoethanol (Lilie et al. 
(1998) and De Bemardez Clark (1998) are used in sufficient amounts to obtain 
maximum reduction of all cysteine residues present. These reducing agents are 
important factors in preventing non-native intra- and inter-disulfide bond formation in 
highly concentrated protein solutions at alkaline pH. It is important to mention that the 
model protein (Con A) used in the current project lacks disulfide bridges therefore the 
use of these reducing agents is out of question.
(4) pH and Temperature
pH has always been a key factor in the attainment of complete solubilisation, since at a 
certain pH the protein can unfold completely. However, at the same time extreme pH at 
both ends (very low and very high) could have an unfavourable effect on the protein in 
question because of irreversible chemical modifications. Scientists like Khan et al. 
(1998); Patra et al.(2000); and Hartman et al. (1999); investigated the use of high pH 
(>12) to solubilize growth hormones and pro-insulin. Some studies as reports from Patra 
et al.(2000) have explored different solubilisation methods for the recovery of human 
growth hormone from E. coli inclusion bodies and obtained the same results of 
solubilisation efficiencies when using 8 M urea, 6 M GdmCl, 1% SDS or 1% CTAB (all 
at pH 8.5) or 2 M urea (at pH 12.5).
(5) In situ solubilisation
Addition of the solubilizing agents directly to the fermentation medium at the end of the 
process is known as In situ solubilisation. The process has its advantages in the 
elimination of time-consuming and energy-consuming mechanical disruption methods
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and also centrifugation or filtration. Although, the release of both proteinaceous and 
non-proteinaceous contaminants that may have to be removed before renaturation is 
attempted are found to be the main disadvantages (Georgiou and Valax (1999); and 
Futami et al. (2000).
1.3 Aggregation
Discussion of folding is not complete unless the obstacles encounter the process of 
correct folding are mentioned, therefore, this part will try to identify the different areas 
of the aggregation process and how scientists and researchers are trying to deal with the 
problems that arise from it. Aggregation is a process which occurs when intra- and 
intermolecular interactions driving protein folding are not correctly balanced during the 
renaturation or refolding process. Hydrophobic interactions are the major source of 
aggregation when the side-chains of a folding protein, or two interacting molecules 
come together there is a favourable increase in the entropy of the system, since, the 
solvent (water) molecules behaves in a random way breaching the ordered environment 
around the exposed hydrophobic surfaces. Moreover, unfavourable apolar-polar 
interactions are replaced with more favourable homo -type interactions leading to 
energy contribution. Because aggregation depends on protein concentration the way to 
tackle this problem is to reduce it by utilizing methods like dilution(see also section 
1.4.2) which provides low concentrations, however, dilution has disadvantages which 
are represented in large volumes of buffers, large vessels and this expenditures lead to 
expensive budgets. Knowing the exact pathway of aggregation may be a good way to 
overcome this barrier since in industry to refold at low costs utilising easy methods, the 
pulse or step-dilution (Rudolph and Fischer, 1990) may be the perfect solution to refold 
at high concentrations. Another source of aggregation is the refolding intennediates; 
these intennediates are formed during the refolding pathway since they are mainly 
composed of secondary structure and lacking tertiary fonns that interact together 
through their exposed hydrophobic surfaces making aggregation possible, hence, divert 
from the folding pathway. The “temperature leap tactic” method (see section 1.4.6) 
developed by Wetlaufer and Xie tried to offer a solution by sudden rising of temperature 
after cold incubation. The method utilize denaturant concentrations that are less thanlM 
and indicate the formation of the first intermediate instantly from the beginning of the 
refolding process then its isomerisation into the second intermediate and so on until the
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appearance of the fully folded native structure providing that suitable refolding 
conditions are maintained. Goldberg et al., (1996) revealed that aggregation is a non­
specific phenomenon since incorrect disulphide bonding may not be the major cause of 
aggregation when they explored the nature of the different interactions responsible for 
aggregation during folding. On the contrary, (Speed et al., 1996) argued that larger 
aggregates could grow by a different mechanism involving non-specific interactions and 
their hypothesis was confirmed by (Maachupalli-Reddy et al., 1997) proved that the 
non-specific nature of the aggregation reaction as foreign proteins are likely to 
aggregate when folded in isolation. Hydrophobic interactions are the main cause of 
aggregation which is a fast process that occurs on the first minute of the refolding 
process while the aggregate size and not the concentration increase by time. Specific 
precautions are taken to reduce aggregation as (Katzav-Gozansky et al., 1996) identified 
mutations that disrupt the hydrophobic patches and the use of antibodies that bind them 
respectively; therefore, both strategies have the same goal in tackling the aggregation 
problem by preventing available hydrophobic interactions.
1.4 Protein Refolding
1.4.1 Introduction
The previous sections discussed some of the different aspects of folding and the 
problems that are facing the production of the correct folded proteins. Refolding is the 
bottleneck in the protein science since scientists are trying to find suitable methods and 
schemes to improve the renaturation yield, knowing that every protein is different and 
specific in its nature. Thus, refolding is a procedure that is in rapid improvement to 
facilitate the correct folding of recombinant proteins produced by the utilization of 
inclusion bodies, where, aggregation is the major problem that is challenging it and 
trying to overcome this barrier is a trial and error pathway. Different techniques are 
tried focusing on the efficiency of the refolding and the maximum renaturation yield. 
Moreover, the economical use of these techniques and their effortless adoption by either 
research or industry directed a discussion in the forthcoming section to explore the 
different procedures that scientists are trying to improve, and investigate their benefits 
and limitations.
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1.4.2 Dilution (Rapid or Continuous)
In section (1.3) dilution was discussed as a method that to some extent improves the 
refolding yield that proceeds via first order kinetics while reduces the aggregation 
process following high order kinetics that is concentration dependant. In the current 
project dilution (Rapid or Continuous) is used as a basic method of refolding throughout 
the practical investigations as Middelberg (2002), and De Bemardez Clark (2001) 
reported an improvement in renaturation yield when refolded at low protein and 
denaturant concentrations and also for its simplicity, and economy as the solubilised 
protein is directly or continuously diluted into the refolding buffer. Although it is a 
perfect method when applied in small scales it has limitations at larger scale: the need 
for large volumes of refolding buffers and containers make it less economical and time- 
consuming in industry (Vallejo and Rinas, 2004). While this method increased the final 
renaturation yield and noticeably reduced aggregation Tsumoto et al (2003) added an 
insight into the rapid and continuous dilution when confirmed the role of the denaturant 
concentration in both methods. The Tsumoto groups’ data indicated that the gradual 
increase in the denaturant concentration from the zero point to the final diluted 
concentration allows for a comparison between the start and final phases of refolding 
which is found to be insufficient to refold oligomeric proteins and, therefore, the 
application of rapid dilution is more appropriate in this instance. The previously 
mentioned reviews led the scientists to think of a method that can combine the 
simplicity and low cost of the dilution method with improved efficiency in obtaining 
excess renaturation yield as will be discussed in the next section as the pulse 
renaturation method.
1.4.3 Pulse Renaturation
A breakthrough improvement to the previous dilution method developed by (Rudolph 
and Fischer, 1990); depends on intervals or semi-continuous additions of soluble 
denaturant increasing the protein concentration in the media with each addition (Katoh 
and Katoh, 2000; Vallejo and Rinas 2004; Buchner et al. 1992; and Tershima et al.
1996). Furthermore, the method achieved high yields while refolding at high protein 
concentrations, thus, the knowledge of the final refolding kinetics, the volume of each 
addition corresponding to the maximum refolding yield (critical concentration above
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which aggregation appeared), the maximum concentration of denaturant that gives rise 
to high yield, and the time interval between each addition which allow for sufficient 
refolding is crucial (De Bemardez Clark et al. 1999; Ming Li et al. 2003; and Singh and 
Panda, 2005).The method has advantage; the increase in the final renaturation yield, 
prevention of aggregation when the accumulation of the refolded particles is avoided, 
and also minimizing of the volumes of refolding buffers. On the other hand, the main 
drawbacks are the search for the suitable refolding buffers and the use of additive 
enhancers (Middelberg, 2002). The current studies have exploited the use of the pulse 
renaturation technique and step-wise additions and report the adaptation of the method 
to the model protein used.
1.4.4 Mixing
An important addition to both the methods of dilution and pulse renaturation used as 
part of the refolding techniques in the current studies, where, it keeps the concentration 
of both the denaturant and the protein constant as it helps in the formation of refolding 
intermediates through the rapid collapse of the protein (Tsumoto et al.2003; Jungbauer 
and Kaar 2007) reviewed the effortless use of mixers in devices composed of tankers 
and stirrers needed to apply the method in small scales, however, they reported the 
disadvantages of this methods due to inefficient mixing that can raise the possibility of 
aggregation and also the increase in time when applied in large scale production. A 
device relating mixing intensity to oscillatory Reynolds number (Reo) is called the 
oscillatory flow reactor was developed by Lee et al., (2002, and 2001); overcome this 
barrier by a better mixing uniformity. Furthermore, Hohenblum et al. (2004) and 
Schlegl et al. (2005 a, and b); reported the use of continuous stirred tankers to eliminate 
denaturing reagents from the refolding medium to insure optimum refolding 
environment and also to reuse the aggregated protein to increase the overall yield.
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1.4.5 Dialysis
Previously two types of dilution have been discussed and now in this section an 
exploration of the different opinions concerning the dialysis technique which is a 
modified method of the ordinary dilution will be held. As was mentioned before these 
techniques depend on the speed at which the denaturant concentration is decreased and 
also the length of time that the protein subunits spend during an intermediate denaturant 
concentration to reach the final fully refolded native structure. In contrast to the above 
methods, this technique differs in that; the change from denaturing to native buffer 
conditions occurs gradually. Thus, from what have been discussed in different parts of 
this introduction this will initiate the presence of folding intermediates which leads to 
aggregation (Tsumoto et al. 2003).As this procedure can be excellent in the refolding of 
some proteins it can be modified into a step-wise manner adopting a process that induce 
the unfolded protein first with high denaturant concentration then adopting middle 
concentration in the second step and finally low concentration in the third step 
(Kumagai and Tsumoto 1998; and Tsumoto et al. 1998) as an equilibrium should be 
reached at each step before starting the next one. Advantages of this procedure are 
illustrated in that at intermediate denaturant concentration misfolding or aggregation 
might occur but at the same time denaturant intermediate concentration allows for the 
reverse formation of the folded structure. Furthermore, the process can affect the 
refolding of multi-domain proteins as each domain may refold on its own since their 
folding using the one step dialysis causes aggregation.
1.4.6 Temperature
Incubation temperature is considered one of the potential factors that affect the purified 
yield either positively or negatively (Vallejo and Rinas, 2004; Buchner et al., 1992; 
West et al., 1998; Yoshii et al., 2000). Although, several scientists had pointed out the 
effect of low temperature on the slowdown of the refolding process (Yoshii et al., 2000) 
they also appreciated its role on the prevention of hydrophobic aggregation. While, De 
Bemardez et al. (1999) insisted on an incubation temperature of 15°C as the 
recommended starting point to refold new proteins, some scientists like (Xie and 
Wetlaufer, 1996) refolded proteins at low temperatures, to minimize aggregation, and
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then rapidly raised the temperature to promote fast folding after the intermediates 
responsible for aggregation have been depleted ensuring high yields production. During 
the current project a study has risen from the above mentioned information to 
investigate the different refolding incubation temperatures starting from as high as 
37°C to as low as -5.5°C, hence, exploring their effect on the refolding yield and 
aggregate formation.
1.4.7 Chemical aids
1.4.7.1 Guanidine hydrochloride (Gnd-HCl)
One of the strongest chaotropic denaturant that has been generally used to disrupt the 
ordered state of protein native structure. Its primary mechanism is to affect the energy 
of stabilization, hence affecting the entropy which enables order in the native structure. 
In addition, it also affects the enthalpy energy derives the non-covalent interactions, 
hydrophobic interactions, hydrogen bonds, and ionic bonds. Gnd-HCl works on the 
native state to disrupt the ordered conformation of the hydrophobic interactions 
misshaping a compact globular protein molecule to an open chain with loose core 
where, it requires lower amounts of denaturant to succeed to the fully folded protein. 
Although proteins have been successfully refolded from the denatured state, it may 
prove to be difficult to fold proteins from a partially folded state as the determinant step 
is the suitable minimum amount required to solubilise the protein and to allow for full 
bioactivity recovery in the refolding step as (Singh and Panda, 2005) observed the role 
played by low denaturant concentrations (1-2) M on improving the refolding yield. 
Other chaotropes such as alkyl-urea or organic co-solvents like carbonic acid amides 
may be used to improve in vitro folding (Rudolf and Lillie, 1996).
1.4.7.2 L-arginine
A popular additive used extensively in research recently is L-arginine as it has the 
advantage for partially folded chains where it enhances the solubility of the refolding 
intermediates (Vallejo and Rinas, 2004). As it was found that L-arginine-HCl increases 
the yield of renaturation of human tissue-type plasminogen activator from E. coli
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inclusion bodies, other proteins were tried also, among them antibody Fab fragments, 
single-chain immunotoxins, or casein kinase II. Rudolf and Lillie (1996) indicate the 
stabilisation effect of L-arginine with proteins other than cytochrome C which showed a 
slight destabilizing effect of L-arginine.
1.4.7.3 Glycerol
Glycerol an alcohol aid in the improvement of the refolding environment is one of the 
viscogenic cosolevents widely used in research because it has little effect on pH and 
does not alter the protein native configuration. Glycerol is considered as a stabilising 
agent that when used in high concentrations mixes with the mature folding 
intermediates during the refolding phase, thus, reducing the aggregation process (Meng 
et al., 2001). The current project investigates the role played by glycerol in the 
improvement of the refolding of Concanavalin A in a step to optimise its refolding 
conditions.
1.4.7.4 Detergents
Ionic and non-ionic detergents have been extensively used in the solubilisation of 
inclusion bodies; however, (Tandon and Horowitz, 1996), had reported the use of lauryl 
maltoside in the refolding of the globular protein rhodanese to suppress aggregation and 
improve the refolding capacity of the refolding buffers. Other detergents were also put 
under trial (1) Non-ionic detergents like Tween20, TritonX-100 and octylglucoside, (2) 
Ionic detergents like SDS, cetyltrimethylammonium bromide, and (3) Zwitterionic 
detergents, all were found to refold perfectly the globular protein rhodanese with the 
lauryl maltoside having the maximum recovery activity. The detergent properties of 
TritonX-100 used in the present project are further explored in a separate study to reveal 
its effect on the refolding of Concanavilin A.
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1.4.7.5 Chaperones
Chaperones are a naturally occurring group of proteins aiding in vivo protein folding 
and protecting cellular proteins from different types of environmental conditions by 
minimising protein aggregation (Vallejo and Rinas, 2004).
Natural chaperones have also been used for in vitro protein refolding but their high cost, 
high concentration, and the need for their removal after the refolding process, restricts 
their wide application. Chaperones are not suitable large-scale refolding processes 
(Vallejo and Rinas, 2004).
Some detergents have been viewed as artificial chaperones because they may resemble 
the mode in which a natural chaperone acts through the formation of a protein complex. 
Refolding depends on the removal of the added artificial chaperone. The release of the 
folding-competent protein is initiated by the addition of cyclodextrins. Cyclodextrin 
polymer beads are used in the removal of the cyclodextrin-detergent complex by 
centrifugation and are also used in expanded-bed columns in semi-continuous refolding 
processes (Vallejo and Rinas, 2004).
1.4.8 Chromatographic Refolding
Chromatography is one of the important methods in achieving correct refolding of 
inclusion bodies. Three methods comprise the major or the most used techniques in 
research and industry: affinity chromatography [using immobilized metal chelates 
(IMAC) or bio-specific binding], size-exclusion chromatography (SEC), and ion 
exchange chromatography (IEC). Changes have been made to these processes since they 
were first used in the 1990s to improve the overall renaturation yield and the recycling 
of aggregates.
1.4.8.1 Affinity chromatography
1.4.8.1.1 Immobilized Metal Affinity Chromatography (IMAC)
A popular and efficient method used in the purification and refolding of tagged proteins 
depends greatly on the formation of high affinity complexes with immobilised divalent
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metal ions. Refolding can be achieved as has been described by (Vincent et al. 2004) by 
a simple buffer exchange in a stepwise manner where the gradual reduction of the 
denaturant through use of a gradient to initialise folding of a protein is common 
practice. A major disadvantage of the technique when the adsorbed protein 
concentration is high at the point of pouring the refolded sample onto the column for 
aggregates can form and the elution yields become low. Although, redox- systems are 
required for proper refolding they have to be adjusted very carefully in IMAC by 
performing of a buffer exchange since interactions of some metal ions, like Cu+2 which 
forms mis-paired disulphide bonds can occur (Stempfer et al., 1996). Furthermore, due 
to the increase in hydrophobic forces at high salt concentration initiating the aggregation 
of folding intermediates optimisation of binding, washing, and refolding conditions 
should be considered a fact that was mentioned by (Jungbaur et al., 2004) in a study 
about chromatographic beds used in folding and refolding of proteins.
1.4.8.1.2 Bio-specific affinity chromatography
This technique depends on the ability of a protein to bind to an immobilised form of its 
natural ligand or substrate. In the case of Con A, which binds to mannose and glucose 
derivatives, a convenient immobilised ligand already exists as the glucose-polymer 
dextran. This method was first used for Con A purification directly from crude jack 
bean meal extracts (Concanavalin A as a tool) and was subsequently used for 
recombinant forms (Min et al., 1992). Sephadex G-75 is used as the pre-formed affinity 
matrix and methyl-a-D-mannopyranoside is used as bio-specific eluant since it is the 
mono-saccharide of highest affinity for Con A.
1.4.8.2 Size-exclusion Chromatography (SEC)
Technique depends on the size of the porous structures of the gel to differentiate 
between the aggregate forming folding intermediates and refolded subunits by their 
hydrodynamic radius and also to recycle these aggregates through the use of the delayed 
running front of the denaturant. The method is conducted by injecting the denaturant 
mixture of the protein onto the previously equilibrated columns and the concurrent 
elution of it with refolding buffers results in high yields compared with the common
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used dilution techniques. Precautions should be taken using this technique as injecting 
of denaturant proteins of high concentration or eluting at high rates can lead to 
aggregate formation and reduces overall renaturation yields (Vallejo and Rinas (2004).
1.4.8.3 Ion Exchange Chromatography (IEC)
A method based on the binding of the unfolded denatured protein to the matrix. 
Introduction of the pH gradient increased the efficiency of the technique by improving 
the elution yield as observed by (Gu et al., 2002). Low salt concentrations represent a 
way of improving the ion exchange technique as it reduces the possibilities of 
hydrophobic interactions forming intermediate aggregates, thus, improving the refolding 
yield (Schlegl et al., 2003). However, the technique as described provided more protein 
purification than other chromatographic techniques for crude samples the while the size 
exclusion proved to be more adequate in the utilization of the partially purified ones.
1.5 Concanavalin A (Con A)
1.5.1 Introduction
Concanavalin is one of the plant lectin proteins separated by Sumner (1919) into two 
crystallisable fractions, Concanavalin B and Concanavalin A according to their 
solubility in NaCl. Since that time Concanavalin A has been known as having 
agglutination activity that precipitate erythrocytes, starchy mucins and glyco- proteins 
(Sumner and Howell, 1936). Its carbohydrate binding activity was further revealed by 
(Goldstein and Poretz, 1986) in showing specificity in binding saccharides containing 
a-D-mannose or a-D-glucose residues and also the possibility of binding oligo­
saccharide sequences lacking these units. Concanavalin A of the jack bean (Canavalia 
ensiformis) was selected as a model in the present work to optimise the refolding 
conditions of a recombinant protein. The term Con A will be used through out the 
remaining of this manuscript to identify the protein. Con A was chosen on specific 
criteria presenting it as an ideal model since it owns agglutination and carbohydrate 
binding activities, and the reaction with dextrans affords an easy and inexpensive 
method for its purification through affinity chromatography (see section 1.4.2.1). 
Furthermore, many types of bacteria agglutinate well with Con A marking it as an
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invaluable tool in many areas of research. Con A interact actively with cell surface 
receptor carbohydrates, and has an impact on cells transformed by oncogenic viruses, 
hence inhibits growth of malignant cells in animals, and exhibits mitogenic activity. 
Naturally Con A exists in tetramer form Figures (1.2, a and b); however, following 
change in pH and temperature patterns it can exhibit monomer and dimer structures.
1.5.2 Chemical structure
The chemical structure of the lectin Con A appeared to be consisting of ellipsoidal 
domes of dimensions 42 X 40 X 39 A (Becker et al., 1976). Each subunit of it consists 
of 237 residues and contains two metal sites necessary for saccharide binding. One site 
binds transition metal ions, manganese, while the other favours binding calcium Figures 
(1.3, a and b) showing skeletal and Stereo views of Con A protomer, and (Figure 1.4) 
showing the complete amino acid sequence of Con A.
1.5.2.1 Polypeptide Chains
The folded polypeptide chain is mainly formed of two anti-parallel pleated P sheets 
with the presence of a twisted sheet of seven strands extending all through the centre of 
the molecule and a semi- curved sheet of six strands which forms the back surface of the 
monomer. Any disturbance to the P sheet structure leads to the collapse of the cleavage 
between residues 118 and 119 and, therefore, the unfolding of the pleated sheet. The 
NH2- COOH-termini and the metal binding site occur on the right of the twisted p sheet 
(Becker et al., 1976).
1.5.2.2 Metal Ion Binding Sites
The metal mainly (Manganese and calcium) binding sites are present in an octahedral 
structure having four protein groups and two water molecules as ligands (Hardman et 
al., 1982; Weisgerber and Helliwell, 1993; Naismith et al., 1993; Emmerich et al., 
1994).The binding site of Mn2+ allows for the binding of other metals for example
^ 1 ^ t ^  1 ^  1
Co , Ni and Cd . The protein ligand for Ca are the side chains of Asp 10, Asn 14,
94-Asp 19, and the carbonyl oxygen of Tyr 12. In addition, Mn has the ligands which are
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the side chains of Glu8, Asp 10, Asp 19, and His 24 all are bound to two water 
molecules (Concanavalin A as a tool) Figures (1.5 a and b) showing metal and ligand 
binding sites for the four Con A subunits.
27
ton
ton
C o
F igu rel.2a  Schem atic diagram  o f the Con A  tetram ers
The four subunits showed in a heavy outline, are related by D 2 point symmetry. Binding sites for Ca2+, 
Mn2+, and specific saccharides are indicated by Ca, Mn, and S, respectively. Adapted from (Reeke et al., 
1975). The covalent and three-dimensional structure o f  Con A. IV Atomic coordinates, hydrogen 
bonding, and quaternary structure. J. Biol. Chem. 250: 1525-4
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Figure 1.2b Ribbon representation of the Con A tetram er (crystal structure)
Polypeptide backbone for each subunit is drawn as a different coloured ribbon in yellow, blue, pink and 
green. The two divalent metal ions are shown as spheres: M ir in yellow and C’a~ in cyan. Bound mono­
saccharides (mannoside) are also shown as Van der Waals spheres with oxygen in red and carbon in 
black. Dimers existing in solution are formed by association between the yellow and blue subunits, and 
also by the pink and green subunits. Reproduced from (Naismith et al., 1994). Acta Cryst. 50: 847 -  858)
29
Figure 1.3a Skeletal model of the Con A protomer viewed down the z axis
[110] is horizontal, [110] is approxim ately vertical. The 2- fold axis relating members o f an ellipsoidal 
dimer (second protomer not shown) is roughly perpendicular to the illustration at the bottom center. The 
metal atoms are represented by the two white spheres at the top o f  the model. The B-IPG iodine-binding 
site is indicated by the sphere at the lower right. Sheet containing 14 hydrogen bonded chains, 7 from 
each monomer. Other interactions between halves o f  the ellipsoidal dimer apparently involve residues ST­
BS, 136-140, and 177-ISO. Reproduced from (Edelman et al., 1972). Proc. Nat. Acad. Sci. USA, 69: No. 
9, pp. 25S0-25S4.
Figure 1.3b Stereo drawing of the a-carbon backbone of the Con A protomer
Figure 1.3b oriented as in Fig. 1.3a the positions shown for residues 34 and 35 are tentative. Computer- 
drawn stereo figure was made by the program OR-TEP o f  Dr. Carroll Johnson. Reproduced from 
(Edelman et al., 1972). Proc. Nat. Acad. Sci. USA, 69: No. 9, pp. 2580-2584.
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1.5.2.3 Saccharide Binding Sites
The elaborate research of many scientists to investigate the ability of Con A to bind 
saccharides has given an insight into the true structure and function of its biological 
activities Figures (1.6 a and b) showing stereo views for the saccharide binding sites 
with networks of hydrogen bonds and metals. These studies identified specific mono­
saccharides that can affect the biological activity of Con A, like D- glucose and D- 
mannose with the exclusion of other carbohydrates such as D- galactose. On the other 
hand, the presence of hydrophobic regions beside the saccharide binding sites 
strengthens some sugars as inhibitors than those without them (Goldstein et al., 1965; 
Poretz and Goldstein, 1970; and Goldstein et al., 1974). (Naismith et al., 1994; and 
Naismith and Field, 1996) described the Manoside binding site of Con A, also 
Kanellopoulos et al., (1996) observed the tri-Mannoside core found in N-linked glycans 
which explain the high affinity of Con A for these glycans and also reported a similar 
saccharide binding site for the 48-nitrophenyl-a-D-mannopyranoside complex Figures 
(1.7 and 1.8). Becker et al., (1976) indicated the interactions between the binding sites 
and the hydrophilic and hydrophobic regions in a study conducted on the inhibitor /3- 
oiodophenyl - n-glucopyranoside binding sub-sites.
In addition, the study concluded that the binding mode of the protein depends on 
whether it occurs in solution or in a crystalline state.
Farina and Wilkins (1980) also Troganis (1992) and other scientists have examined the 
role played by the aglycon group in binding and the determination of the various 
binding constants experimentally indicated their assistance in binding. Good quality 
crystals of Con A-saccharide complexes have been produced for a series of such 
compounds, which diffract at medium resolution, and X-ray diffraction data have been 
collected for several complexes. In a report by Kanellopoulos et al. (1996) the structure 
of the complex with 48- methylumbelliferyl-a-D-glucopyranoside (a-MUG) at 2.78 A 
resolution has been described. However, Kanellopoulos et al. (1997) also revealed the 
crystal structures of complexes of Con A with 48-nitrophenyl-a-D-mannopyranoside (a- 
PNM) and 48-nitrophenyl-a-D-glucopyranoside (a-PNG), which indicates the higher 
affinity of Con A for Mannosides than for glucosides. However, it was recently
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Figure 1.4 Amino acid sequence of mature Con A
Residues interacting directly (solid lines) or through water molecules (dashed lined) with the metal ions 
o f  Con A are enclosed in boxes. The sites o f  cleavage by CNBr are indicated by solid arrows and the 
natural cleavage occurring in some molecules o f  Con A  is showed by a wavy arrow. Reproduced from 
(Becker et al., 1976) The Molecular Structure o f  Concanavalin A. In: Bittiger, H., and Schnebli, H. P. 
(Eds) Concanavalin A as a tool, W iley and Sons pp 33-5
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Figure 1.5a Metal-Ligand and saccharide hydrogen bonding distances for Con A subunits
Metal-Ligand Distances and Saccharide Hydrogen Bonding Distances for the Four Subunits.
Reproduced from (Hamodrakas et al., 1997). Journal o f  structural biology 118: 23-30
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Figure 1.5b M etal-binding sites o f Con A
The m etal-binding sites SI and S2 depicted in terms o f  atomic displacement ellipsoids. Reproduced from 
(Deacon, A., 1997). J. Chem. Soc., Faraday Trans., 93(24).
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reported by (Srinivas et al., 2001) that oligomerisation may victimise the lectin’s from 
acquiring it’s full biological activity. Dimeric Con A was found to possess binding 
affinities for sacchrides containing 1 and 2 or 5 mannose sugars like these of the 
tetrameric structure. Figure (1.9) indicates the three structures of Con A (monomer, 
dimmer, and tetramer).
1.5.3 Covalent and Three Dimensional Structures
The amino-acid sequence using dansyl-Edman procedure contains 237 residues and 
three-dimensional structures of the lectin Con A has been determined. The sequences of 
three short stretches were assigned on the basis of x-ray crystallographic data. 
Interpretation of an electron density map at 2-A resolution indicates that the 
predominant structural element is an extended polypeptide chain arranged in two anti­
parallel pleated sheets or 13- structures. Residues not included in the 13 -structures are 
arranged in regions of random coil. One of the pleated sheets contributes extensively to 
the interactions among the monomers to form both dimers and tetramers. The positions 
at which Mn2+, Ca2+, and saccharide are bound to the protein, and the point of 
cleavage for the formation of the naturally occurring fragments Ai and A2, have been 
tentatively assigned. Both metal-binding sites are at least 20-A removed from the 
position at which saccharides are bound. The saccharide-binding site is a deep pocket of 
approximately 6A x 7.5k x 18k, the inner portion of which is occupied by hydrophobic 
residues (Edelman et al., 1972).
1.5.4 Binding and functional properties
The binding of Con A to various structures via hydrophobic interactions has been 
studied using a variety of physicochemical assays. It is found that Con A binds to non­
polar compounds such as the plant auxin /Iindoleacetic acid and its structural analogue 
tryptophan and that this binding is independent of the saccharide binding activity 
normally associated with the lectin. The results of equilibrium dialysis experiments on 
the binding of /a-indoleacetic acid were consistent with the presence of a single weak 
binding site per subunit of protein, having an association constant of about 7 x 10’ M- 
Competition experiments using various non-polar compounds such as oiodobenzoic
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Figure 1.6a Stereoscopic view o f the saccharide-binding site
The bound saccharide molecule is superim posed on the difference-electron density map (blue) together 
with the portion o f the protein which constitutes the site. Hydrogen bonds are shown as broken lines. See 
Figure 1.5b for a detailed view o f  the hydrogen-bonding network. The methyl substitute o f 0-1 has not 
electron density and is not shown in the figure. Reproduced from (Derewenda, Z. et al., 1989). The 
EMBO Journal 8: no.8 pp .2189-2193.
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Figure 1.6b Stereoscopic view of the saccharide-binding site
Showing the network o f  hydrogen bonds which stabilizes the interaction between the protein and the 
saccharide. Calcium and transition metal are shown as white and pink spheres. Bonds between the metal 
ions and their ligands are not shown in this figure for the sake o f  clarity. Reproduced from (Derewenda, 
Z. et al., 1989). The EMBO Journal 8: no.8 pp .2189-2193.
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Figure 1.7 The c-carbon backbone of a tetramer of the Concanavalin A
View in the y-direction showing the proximity o f  the bound mannoside molecules in one Concanavalin A  
dimer to the mannoside bound to the adjacent tetramers. Each o f  the two pairs o f  proximate sites is related 
by a local pseudo-dyad axis normal to the xz-plane. (b) V iew in the x-direction showing the proximity o f  
each o f the bound mannoside molecules in the second Concanavalin A dimer to the surface o f  an adjacent 
tetramer. Locations o f  bound mannoside are labeled MAN. Reproduced from (Derewenda, Z. et al., 
1989). The EMBO Journal 8: no.8 pp.2189-2193.
39
Figure 1.8 M ethyl a-D-inannopyranoside (PDB 5CNA)
(Overlaid onto the saccharide-binding site of saccharide-free Concanavalin A at 0.94 A resolution)
Electron density map (2F indicates the positions o [Fc) o f water molecules (top left), Asp208 (top right) 
and A snl4  (bottom left). Reproduced from (Deacon, A., 1997). J. Chem. Soc., Faraday Trans., 93(24).
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Figure 1.9 Tertiary structure o f Concanav alin A (m onom er, dimer, and tetramer)
(a) Tertiary structure o f Concanavalin A monomer described as ‘Jelly ro ll', (b) dimerisation in Con A (c) 
the tetramerisation o f the two dimers. Adapted from (Srinivas, V. R., Bhanuprakash Reddy, G., 
Ahmad, N., Svvaminathan, C. P., Mitra N., and Surolia A., 2001). Legume lectin family, the natural 
mutants o f quaternary state’, provide insights into the relationship between protein stability and 
oligomerisation. Biochim. Biophys. Acta. 1527: 102-111).
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acid suggested that this hydrophobic binding site is located in the same cavity which 
binds the iodine containing ligand as shown by x-ray crystallography.
Con A also binds to lipid vesicles composed of dipalmitoylphosphatidylrholine . This 
binding to lipid membranes raises the possibility that the synergistic effects of Con A 
and tetradecanoyl phorbol acetate on lymphocyte mitogenesis may be due in part to an 
interaction between the lectin and the phorbol ester.
1.5.5 Biosynthesis of Con A
Con A is synthesized in the cotyledons of developing jack been seeds and accumulates 
in the protein bodied of storage-parenchyma cells. Thereby, Con A is synthesized as an 
inactive glycoprotein precursor termed (glyco-pro-Con A). Different pathways are 
followed to produce the peptide backbone of mature form of Con A like 
deglycosylation, endoproteolytic cleavages, and ligation of peptides. Mature Con A is 
not a glycoprotein although its initial precursor (pro-Con A) is glycosylated. The 
precursor pro-Con A, after being secreted to the endoplasmic reticulum and transported 
to the protein bodies is activated by deglycosylation to pro-Con A (Bowles et al., 1986; 
Chrispeels et al., 1986) this is a vital stage in the lectin activation Figure 1.10 (Jones 
(1995). Moreover, (Sheldon et al. (1992 and 1998); Ramis et al. (2001) indicated that an 
acidic medium is needed beside the deglycosylation to activate the pro-Con A in the 
plant.
Deglycosylation occurs after the peptide splicing on the 15-residue loop (on the loop of 
the residues 120-135) of the pro-ConA approximately in the middle of the molecule 
(Figurel.10). Figure 1.11: has shown the cleavage and ligation of Con A biosynthesis 
indicating two intermediates comprised of A chain of apparent Mr 18 K and composed 
of 9 residues of the C-terminal extension of pro-Con A and 4 residues from the spacer 
peptide corresponds to residues 1-118 of mature Con A. Furthermore, (B chains) of 
apparent Mr 14 K precursor’s equivalent to residues 119-237 of mature Con A 
(Figurel.llb). F igurel.lld  shows ligation at residues 118-119 resulting in 
rearrangement of sections A and B of apparent Mr 30 K when Mature Con A sequence 
is synthesized in the jack beans. No junction at 118-119 present in the mature plant 
produced two native fragments, one a peptide of apparent Mr of 16 K (A chain)
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equivalent to residuesl-118 the other of apparent Mr of 14 K corresponding to residues 
119-237 (B chain), (Figure 1.1 le), (Min and Jones, 1994).
1.5.6 Purification of Con A
The present project is dealing with the refolding part of the purification of Con A 
affinity chromatography and dextrans as Sephadex G-75 are used. Here in this section is 
a brief description of the technique which has been firstly mentioned by Sumner (1919) 
who indicated the isolation of the crystalline form by dialysis of sodium chloride extract 
of the jack bean meal. Although, the method is described as a simple technique that uses 
aqueous acetone extract of jack bean meals, methods have been developed to purify Con 
A that widely differ from the first time. Scientists like Goldstein and Poretz (1986) 
developed a method exploiting the sacchride binding characteristics of the lectin in 
affinity chromatography that made the purification of crude Con A accessible. Columns 
of “Sephadex” (G-25, G-50, and G-75) are prepared and equilibrated with 1.0M NaCl
9-1-(as the method prefer high salt buffer) in addition to metal ions like (Mn and 
Ca2+).Though, Sephadex G-75 and G-50 are perfect for affinity chromatography, 
Sephadex-25 is not recommended due to cross-linking to use as a matrix for Con A. 
Glucose or other sugars in low concentrations are used to elute Con A from the dextran. 
The method produces yields of 2-3grams of Con A per lOOgram of jack bean meal.
43
a -» ■
B
glyco-pro-ConA mature ConA
A
(119) T (119)
Figure 1.10 Post-translational m odifications during Con A  biosynthesis
Summary o f  processing events converting glycosylated pro-Con A  to mature Con A  during development 
o f  immature jack bean cotyledons. Six intermediates, including stages where two polypeptide chains are 
Ribbon representation o f  the Con A  tetramer (crystal structure) e distinct, have been omitted. Amino- and 
carboxy-termini are indicated by N  and C, and the numbers in brackets are residue positions o f  mature 
Con A. The 9 residue C-terminal extension and the 15 residue intervening sequence are shown as solid 
infill the latter carries one N-linked high-mannose oligosaccharide (o , Man; □, GlcNAc). During 
processing in the plant inactive glyco-pro-Con A  is first de-glycosylated (arrow a) - resulting in 
appearance o f  lectin activity. An endopeptidase then cleaves (arrows b, c, d, e) on the C-side o f  four 
asparagine residues, and residues (118) (arrow d) and (119) are ligated enzymatically. Splicing thus 
results in a transposition in the linear arrangement o f  the protein sections designated B [□] and A 
with multi-staged excision o f the glycosylated spacer sequence and nonapeptide tail. The mature lectin 
becomes a circular permutation o f  most o f  the protein sequence o f  its own precursor. Adapted from: 
Jones, D. H. (1995) "Folding, activation and protein splicing o f  recombinant Concanavalin A precursors: 
an exceptional protein to prove some rules" Chap. 20 In  Perspectives on Protein Engineering and 
Complementary Technologies, Geisow, M. and Epton, R. (eds.) Mayflower Worldwide, Birmingham 
(ISBN 0-9515735-2-7).
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Figure 1.11 C leavages and ligation generating Con A
(in jack  beans and com parison with recom binant proteins used to reconstitute splicing in vitro)
(a) Pro-Con A  showing section B, intervening 15 residue sequence (S15), section A, C-terminal 9 residue 
extension (C9). (Regions A  and B not drawn to scale). Residue numbers are shown above with the 
numbering corresponding to mature Con A in round brackets. Apparent Mr, (based on electrophoretic 
migration) is shown in square brackets. Amino acid sequence is given below in single letter code with 
boundaries between regions shown (:), glycosylation site shown (*) and known cleavage sites following  
asparagine residues indicated by arrows, (b) Processing intermediates cleaved from pro-Con A  in jack 
bean detected by pulse-chase labelling (not all intermediate stages are shown), (c) Recombinant 
precursor A and B chains constructed from pIN-pro, expressed separately in E .coli, refolded together and 
affinity purified. The region derived from the intervening sequence is truncated to 11 residues (SI 1) the 
first two o f  which are altered (underlined) as a result o f  D N A  manipulations, (d) Mature Con A sequence 
generated in developing jack beans by ligation at residues 118-119 resulting in rearrangement o f  sections 
A and B. (e) Native fragments detectable in mature seeds, originally designated A l and A2. (Reproduced 
from M in, W . and Jones, D .H., (1994). Nature Struct. Biol., 1: 502-504,).
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1.6 Previous Work in This Laboratory:
Optimising the refolding conditions of a recombinant protein, produced as an insoluble 
inclusion body by over expression in Escherichia coli, may explain certain facts about 
the mechanism of how proteins fold (section 1.2). Many problems face the large scale 
productions of correct refolding process in industry are represented in low yield, high 
cost of reagents and equipment (section 1.4). On the other hand, laboratory refolding 
procedures differ in the use of reagents and vessels considered unsafe and costly in 
industry as detergents, chaotropes, extreme pH or temperature. The use of model 
proteins as tools to unveil different sights about the refolding mechanisms is widely 
accepted in scientific research, however, the way a protein can refold cannot be 
generalised as proteins vary in how they refold to their native structures. More than 
fifteen years have already passed since Min (1992) first used the pIN series of 
expression systems and recommended host strains in our laboratory. Great works of 
successors accomplished vast improvements in yield and protein quality. Mei Li (2001) 
work on expression and refolding of ConA variants added a mark in identifying the 
different aspects of expression and purification for this model. Thus, the present project 
continues from where they have stopped in improving the protein yield and quality 
through following a thread to optimise the refolding of this model protein. The 
knowledge gained from literature (section 1.5) indicated the problems that are 
challenging the correct refolding of Con A and here in this project focused on the 
prevention of aggregation by altering some of the environmental factors that aid in the 
refolding process Figure (1.12).
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1.7 Aims of the Project
The objective of this project is to increase the yield and the quality of in vitro refolded 
proteins over-expressed in E. coli as insoluble inclusion bodies. This can be achieved 
through tackling the problems that initiate aggregation in refolding media (Figure 1.12). 
The specific aims of the project are:
1- To investigate the use of glycerol as a refolding aid that reduces hydrophobic 
interactions, which are the main cause of aggregation and thus low yield.
2- To evaluate the use of low concentrations of guanidine hydrochloride to decrease 
aggregation during refolding.
3- To optimising the dilution factors and dilution protocols to improve the overall 
protein yield.
4- To investigate Triton X-100 as an aggregation suppressor.
5- To explore more deeply how the refolding of Con A proceeds using Triton X-100 as 
a tool to determine the time that the denatured protein takes to reach the completely 
folded structure.
6 - To compare the effect of several sets of temperature ranges from as low as -5.5°C to 
as high as 37°C in order to adjust the optimum in vitro temperature at which Con A 
properly folds to its native structure
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Figure 1.12 In vivo hypothetical folding and m aturation pathway for a dim eric protein
The result o f  the pathway depends on the presence o f  the proper environmental conditions, including 
cofactors, chaperones etc. A heterologous environment can influence the passage o f  partially folded 
intermediates towards the aggregated state. (Reproduced from M itraki, A., and King, J., 1989). Protein 
folding intermediates and inclusion body formation Biotechnology 7: 690-697)
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Chapter Two
Materials and Methods
2.1 Materials Used In Experiments
2.1.1 Chemicals and Reagents
Unless other-wise mentioned, all chemicals and reagents used were of analytical grade. 
These reagents were used without any further purification.
2.1.2 Bacterial strains
Strain Genotype
BL21 (DE3) F" ompThsdSs {tb m b ) gal dcm (DE3)
2.1.3 Plasmid Vectors
The parent expression vector used was pET-26b (+). The plasmid map of the expression 
vector is shown (Figure 2.1). The Con A variant used is:
pET 0MAT_ Mature-Con A coding sequence with ompA ribosome binding site and 
secretion signal inserted as Xbal -  BarriRl fragment into corresponding 
corresponding sites of pET-26b(+).
2.2 DNA Manipulations
2.2.1 Growing colonies
The bacterial cells BL21 (DE3) purchased from Novagen were plated out on LB plates 
without antibiotics and incubated at 37°C for 24 hours. Single colonies were used fresh 
next day.
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Dra 111(5118}
Xho J{JS8)
Not 1(166)
Hag 1(166}
Hind Ht(i73)
Sal 1(179)
Sac 1(190}
ECOR 1(192} 
BamH 1(198)
Nco 1(220}
Msc 1(225)
Nde 1(288)
BspM 1(268)
Xba 1(326)
SgrA 1(433)
Sph 1(589)
ApaB 1(798)
Pvu 1(4417) 
Sma 1(4291)
Cla 1(4108)
NfU 1(4074)
Eco57 1(3763) 
AlwN 1(3631)
Bpu1102 I (80)
.4 o<'9'n
v  T7 transcription/
expression region
pET-26b(+)
(5360bp)
Mlu 1(1114)
Bd 1(1128}
BstE 11(1295) 
^A pa 1(1325}
BSSH 11(1525) 
Hpa 1(1620)
Bsi 1(3388) PShA 1(1959) 
Pfl1108 1(2001)
Sap 1(3099}
Bstt 107 1(2986)
Tth111 l(29G0)
BspG 1(2741)
Fsp 1(2196) 
PpuM 1(2221)
Figure 2.1 Plasmid Map of Expression Vector pET-26b (+) [Novagen]
Unique restriction enzyme sites only are shown. Features: ori -  plasmid origin o f  replication (for ds 
DNA), Kan -  Kanamycin resistance gene, f l  origin -  origin o f  replication for ss DNA in presence o f  
helper phage, lacl -  gene for lac I  repressor protein. The T7 transcription/expression region includes a 
T7promoter/lac operator site (before Xbal site), and a T7 transcription terminator (after Bpul 102 I site). 
[Figure adapted from Novagen Technical Bulletin #71 (1993).]
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2.2.2 Preparation of electro- competent cells
100 ml LB (section 2.4.1.1.) was inoculated with a single colony of E. coli strain BL21 
DE3. The culture was incubated at 37°C from mid afternoon until the next day. 5 ml of 
the incubated culture were used to inoculate 500 ml of LB medium in a 2, 000 ml flask 
(warmed overnight). The cells were incubated at 37°C and their growth was monitored 
at 600 nm until the absorbance reached 1.5. At this density the cells were chilled on ice 
for 20 minutes. For all the subsequent steps of washing the cells, tubes and solutions 
were kept ice-cold. The cells were divided into two 250 ml aliquots and were harvested 
by centrifugation at 4,000X g for 15 minutes using a Beckman Avanti J 20 rotor. The 
pellets were re-suspended each in 250 ml of sterile 10% glycerol (pre-chilled on ice) 
making slurry of the pellet in a small amount of the 1 0  % glycerol first and spun at the 
same speeds. Again the pellet was discarded and the cells were re-suspended in 125 ml 
of 10% glycerol using the slurry method. The re-suspended cells were combined into 
one centrifuge bottle, balanced using discarded glycerol from first wash, and spun 
again. Subsequently the supernatant was poured off and the pellet was re-suspended in 
20 ml of sterile 10% glycerol. Balancing against 20 ml 10% glycerol followed 
centrifugation at 4,000 x g for 15 minutes at 4°C. Again the supernatant was discarded 
and at this step the pellet was re-suspended in 2 ml sterile 10% glycerol. Finally 0.5 ml 
aliquots of the cells were placed in 40 pre-cooled labelled 1.5 ml micro centrifuge tubes. 
The tubes were sealed, snap frozen with liquid nitrogen and stored at -70°C.
2.3 Transformation of competent cells by electro-poration
Both DNA sample and the competent cells from -75°C were placed on ice. 0.5pl of 
DNA (plasmid preparation) was transferred to the tubes containing 50 pi of competent 
cells. After 20 minutes on ice, approximately 55pl of DNA and cells solution was put in 
a pre-chilled electro-poration cuvette. On the electro-poration device (Biorad 
Micropulser™) the bacteria programme was selected. The cuvette was tapped down to 
ensure that the cells were between the plates. It was then inserted into carrier. The 
carrier was pushed in until the electro-porator clicked home firm. The electro-porator 
was activated and the pulse cycle was delivered by pushing the charged button for a few 
seconds until a short beep was heard. Afterwards the cuvette was removed from the
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sample chamber and immediately the cells were recovered with 1 ml of LB and glucose 
0.5% (w/v), and transferred back to the culture tube for 1 hour incubation at 37°C.
Both 200pl and 20pl aliquots of transformed cells were plated respectively onto surface- 
dry LB agar plates containing Kanamycin (30 pg/ml) and incubated overnight at 37°C 
(the 20pl of aliquot of electro-poration mixture was mixed with 180pl LB and spread).
2.3.1 Production of starter inoculum
In order to get more reliable growth and expression , frozen inoculum must be used, so 
next day, for each plasmid trans-formant five typical colonies were selected and placed 
into five universals containing 7.5 ml LB, 0.5 % (w/v) glucose and Kanamycin (30 
pg/ml). The colonies were incubated at 37 °C and their growth was monitored at 600 nm 
until the absorbance had reached 1.7. At this density 750 pi of sterile 80% (v/v) glycerol 
(final concentration 8 %) was added and the universals were swirled to mix. The samples 
were rapidly placed on ice to arrest growth. For each of the 5 typical colonies of each 
plasmid trans-formant 9 aliquots of 0.6 ml and one of 1 ml chilled culture was placed in 
pre-cooled 1.5 ml micro-centrifuge tubes. The tubes were sealed and snap frozen in 
liquid nitrogen. Finally, they were stored in a plastic storage box in the -80°C freezer.
2.4 Protein Techniques
2.4.1 Preparation of Solutions and Media
2.4.1.1 Preparation of LB and Kanamycin liquid medium (2 litre)
Eight flasks containing 500 ml of LB medium each and 100 ml in a Schott bottle were 
prepared by mixing 42g of tryptone (LUCHEFA), 21 g of yeast extract (Oxoid) and 42 
g of NaCl (Fisher Scientific) in water up to 4.1 litre. The solution (original pH about 
6.9) was adjusted to pH 6.0 with 5 M HC1. The medium was autoclaved at 121°C for 20 
min and subsequently was left to cool on the bench. Just before the media were used, 
kanamycin was added to each flask and the bottle to a final concentration 30 pg/ml (0.5 
ml stock per 500 ml) using aseptic techniques.
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2.4.1.2 Preparation of Stock Kanamycin Solution
Kanamycin was dissolved to a final concentration of 30 mg/ml in water. The solution 
was sterilised by 0.22pm filtration and afterwards 0.5 ml aliquots were aseptically 
pipetted into sterile microfuge tubes and stored at -20°C.
2.4.1.3 Preparation of IPTG
2.38 g of IPTG (MW=238.3) were dissolved in 20 ml of distilled water. The solution 
was sterilized by filtration through a 0.22 pm disposal filter. IPTG solution was stored 
in 1 ml aliquots (0.5 M) and stored at -20°C.
2.4.1.4 Preparation of Borate wash buffer (1 litre)
20 mM Borax [7.63 g Na2B4O7.10H2O (Di-sodium tetra borate lOP^O-Analar] and 5 
mM EDTA [1.86 g Na2EDTA.2 H2 0  (Diaminoethanetetra-acetic acid disodium salt- 
DUCHEFA] were added to 1 distilled litre water. The resulting pH was 9.1-9.2, no 
further adjustments were required.
2.4.1.5 Preparation of MOPS metals buffer (1 litre)
1 M NaCl [58.44 g (Fisher Scientific)] and 50 mM MOPS [10.5 g (Sigma)] were made 
up to 1 litre with distilled water. The resulting solution was adjusted to pH 7.0 using 10 
M NaOH. Afterwards, 1 ml was added of each of 1 M CaCl2 and 1 M MnCl2 giving a 
final concentration of each metal of 1 mM. CaCE and MnCb were not added before 
adjusting pH to avoid precipitation. Finally, O.lg (0.1 g/L) of NaN3 (Sodium Azide 
SLR-Fisons) was added to the solution.
2.4.1.6 Preparation of MOPS Refolding Buffer
The preparation of MOPS refolding buffer is the same as the preparation of MOPS 
metals buffer except the final concentration of calcium and manganese were 10 mM, 
therefore 10 ml of each of the stock of 1 M metal solutions Ca and Mn were added 
to 1 L of the buffer.
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2.4.1.7 Preparation of Metals Stock Solutions
1 M Calcium Chloride Dihydrate, 14.70 g were dissolved in 100 ml of distilled water in 
a graduated volumetric flask. For 1 M Manganese Chloride Tetrahydrate, 19.79 g were 
dissolved in 1 0 0  ml of distilled water in a graduated volumetric flask.
2.4.1.8 Preparation of 8 M Guanidine-Hcl for Protein Purification
152.85 g of guanidine-HCl (Sigma) ( 8  M) were at once dissolved by adding 80 ml of 
distilled water to take the solution to 200 ml exactly. The solution was then placed in a 
50°C water bath to dissolve and the volume was checked again when cooled at room 
temperature. Finally, it was stored at room temperature.
2.4.1.9Preparation of Sephadex G-75
The solution is prepared in advance by weighing 5 g of Sephadex G-75 powder (40-120 
pm dry bead diameters, Pharmacia), 100 ml of MOPS metals buffer were added to the 
powder in a glass Duran bottle. Then this was placed in a boiling water bath to swell the 
Sephadex gel. The water was brought to boiling on a hot plate and the solution was 
simmered for half-hour. Subsequently the solution was left on the bench to cool 
overnight. Then was stored at 4°C.
2.4.1.10 Preparation of Mannoside Elution Buffer
0.1942 g (10 mM) Methyl-a, D-Mannopyranoside (Sigma) was dissolved in 100 ml of 
MOPS metals buffer and a trace of Azide was added.
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2.4.2 Growth and Induction of Cells
As described previously (Section 2.4.1.1) eight conical flasks (4 litre), each including 
500 ml of sterile LB medium and a bottle (Schott) containing 100 ml of LB medium 
were prepared and pre-wormed overnight at 37°C. 100 pi of Kanamycin solution was 
added to 100 ml LB medium in the bottle. 5 ml of the starter medium (LB and 
Kanamycin) was transferred from the bottle to eight universal tubes (Sterilin). Also, 0.5 
ml of thawed kanamycin stock solution was added to the 500 ml LB media in the 
conical flasks, followed by 1 ml of 1 % (v/v) Antifoam (Sigma) sterile suspension.
Eight tubes containing 0.6 ml of frozen inoculum were thawed in the 37 °C water-bath 
for 30 seconds and vortexed for 1 second. Then, using the hood and a sterile pipette, 0.5 
ml of the thawed inoculum was added to each of the eight universals containing the 
starter medium. The top of the tubes were loosened half a turn and secured with a piece 
of sticky tape. The universals and the conical flaks were then incubated for 2 hours at 
37°C/250 rpm. After 2 hours the starter culture in the universals was added to the eight 
conical flasks and incubation was continued.
After about an hour the absorbance of the culture at 600 nm (using a WPA Light-wave 
2 0 0 0  spectrophotometer) was measured at hourly intervals by taking 1 ml sample with 
an automatic pipettor sterilised with alcohol and using distilled water as a blank. At the 
point where (usually after 3.5 hours) the absorbance reading at 600 nm was <2.0, 1 ml 
of IPTG solution was added to each of the eight flasks to a final concentration of ImM 
and growth was continued for a further 3 hours.
After the three hours, a final cell density reading was measured and then mixing of the 
cells was conducted for the eight flasks to remove any variations that might occurred in 
the overall growth culture, then (first 250 ml of the 500 ml culture) were harvested by 
centrifugation (Beckman J2-21, rotor JA10) at 10,000 rpm for 20 minutes at 4°C. The 
supernatant was discarded and the above repeated for the other 250 ml of the culture in 
the same centrifuge bottle. Finally the cell pellets were placed at -80°C.
During the growth and induction of cells aliquots were taken from each of the eight 
flasks for pH Measurements to follow, changes in pH during growth. Samples were 
taken (1) Before inoculation, (2) Before IPTG addition, (3) and at an hourly interval to 
harvest.
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2.4.3 Extraction of Cells (Preparation of Insoluble Material)
The pellets from 500 ml culture volume were each thawed in 40 ml borate wash buffer 
containing 1 % (v/v) Triton X-100. Then the pellets were re-suspended as much as 
possible with a big glass rod and then in a shaker incubator for 10 min. The solution (40 
ml approximately) was then divided between two Oakridge style centrifuge tubes (50 ml 
size) and sonicated (3x1 min) on hard packed ice to break the cells open. Maximum 
power (tuner) with the probe about 5 mm from the bottom of the tube was used. The cell 
lysate was incubated at room temperature for 1 0  min to 1 hour with gentle mixing on 
the rocker. The cells debris obtained was balanced and centrifuged at 20,000 rpm for 
20min at 4°C in a JA-20 rotor (Beckman J2-21). Then the supernatant was discarded 
and the pellet was kept. The tubes were drained by standing up side down on a piece of 
tissue. The drained pellets were then re-suspended in 20 ml borate wash buffer without 
Triton using 1 X 1  min sonication. The solution was mixed at room temperature for 10 
min to half hour and then was spun down at 20,000 rpm for 20 min at 4°C in a JA-20 
rotor (Beckman J2-21). Again the supernatant was poured off and the pellets were now 
re-suspended in 20 ml of Milli Q H20  using 1 X 1  min sonication and then spun down 
at 20,000 rpm for 20 min at 4°C. Finally, washed pellets were frozen at -80°C.
2.4.4 Extraction of Proteins
The frozen pellets were thawed for a few minutes at room temperature on the bench. A 
glass rod was used to break up the pellets as finely as possible and they were dissolved 
in 3 ml of 8  M Guanidine HC1 dissolved in MOPS refolding buffer. Mixing of extracts 
was also conducted at this point for every set of experiments to remove any variations 
that could arise before either at the growth level or the Guanidine -HC1 level and to 
insure exact refolding conditions. Afterwards, the equal amount of extract for 2 
dissolved pellets was poured (for example 2 x 3 ml = 6  ml) into one Oakridge tube.
2.4.5 Refolding
The refolding techniques differ with each study but in general it was as follows: The 6  
ml guanidine extract containing the solubilised protein was refolded by rapidly adding it 
to 180 ml (30X dilutions) of ice cold MOPS refolding buffer while swirling. The
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refolded extract was kept on ice for 1 hour and then on the bench for another 1 hour. 
Then the extracts were put into two JA-14 (250 ml) tubes and were centrifuged at 
14,000 rpm for 30 minutes at 4°C. Finally, the supernatant was filtered through a tea 
strainer to cold receiving flasks and the clear supernatant was then loaded onto a column 
of sephadex G-75 overnight.
2.4.6 Purification of Con A Affinity Chromatography
For the purification of Con A, affinity chromatography was used. It was performed in 
three steps that are explained through sections 2.4.6.1 to 2.4.6 .3 below. Generally, the 
steps involved (1) the column preparation, where the column was packed with about a 5 
ml bed of sephadex G-75 equilibrated in MOPS metals buffer, (2) The loading of the 
refolding extract to the column overnight at 0 . 1  ml/min and washing of the column with 
about 50 ml MOPS metal buffer at 0.5 ml/min and (3) the elution of the Con A variants 
from the column with 12 ml of 10 mM Methyl-a, D-Mannopyranoside in MOPS metals 
buffer at 0.2 ml per minute. Generally, four columns were run in parallel at one time.
2.4.6.1 Column preparation
First, it was checked that the column was connected to the reservoir (allowing inflow 
when removing the plunger). Then the plunger was removed from the column. The taps 
on outgoing lines were turned to intermediate point to plug. The incoming line tubing 
was clamped in pump, to stop dripping. The column was emptied using a Pasteur 
pipette and washed three times with water by vortexing to disperse previously used 
Sephadex. 5-8 ml of Sephadex slurry was then added to the column topped up with 
MOPS metals buffer and was allowed to settle for 5 min. Subsequently the taps were 
turned to connect lines to empty flasks for outflow. The column was topped up again 
with MOPS metals buffer to overflowing and the plunger was inserted. The plunger was 
stopped 1 cm above the Sephadex bed, its level was checked and the plunger screw was 
tightened. The incoming line was switched back to the MOPS reservoir. The plugs were 
removed from the outgoing tubes. Finally, to compact the column buffer was pumped at 
lml per minute (Pump Setting 2 @ X 10), for 2 minutes.
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2.4.6.2 Sample Loading and Washing Away of Contaminants
As soon as it was ensured that the entire flow path was connected to the sample, 180 ml 
of refolded extract was pumped down the column of Sephadex G-75 at a flow rate of 
0.1 ml per minute (Pump Setting 2 @ XI). After all the Con A protein would have 
bound to the Sephadex, other contaminants were washed away with 50 ml MOPS metal 
buffer at 0.5 ml per minute (Pump Setting 10 @ XI).
2.4.6.3 Elution
The chart recorder and A280 monitor [flow cell spectrophotometer (Pharmacia)] was 
turned on and the range was set at to 2.0 A280- The chart speed was selected to be 0.5 
mm/min, units were adjusted to mm/min and 10 mV full-scale spans were selected. The 
A280 monitor was turned to “SHORT” and zero to zero was adjusted on the chart 
recorder. Also the flow cell spectrophotometer was turned back to 2.0 and the base line 
was adjusted to 2 %. The pen was put down and the chart feed was turned on. The 
protein was eluted from the column at 0.2 ml/min (Pump Setting 4 @ XI) using 12 ml 
10 mM Methyl-a, D-Mannopyranoside in MOPS metals buffer. During elution 12 
fractions (1 ml each) were collected. When elution was finished, a post elution system 
wash was performed. The columns were washed with 50 ml of MOPS metal buffer from 
reservoir at 0.5 ml/min (Pump Setting 10 @ X 1). Finally when washing was finished, 
the flow cell spectrophotometer, chart recorder and pumps were switched off and the 
tubes plugged and released from the pumps pressure plates.
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2.4.6.4 General Design of Experiments
Different protocols of the refolding and binding of the lectin Con A stages were 
investigated in the current project. Some studies explore the effects of additives like 
(glycerol, extra guanidine-HCl, and TritonX-100) on the purification of Con A. 
Therefore a specific design was depicted in Figure 2.2; indicates the practical plan 
followed in these studies.
2.4.6.5 Spectrophotometric Analysis
Absorbance readings at 280 nm were taken for each of the 12 fractions. A Beckman DU 
650 Spectrophotometer was used and conversion factor 0.877 was selected to convert
1 o/A280 readings to mg/ml [E280 °=11.4 for Con A]. 1 ml of Mannoside elution buffer as 
used above was used as a blank. Elution fractions from each flask with absorbance 
readings greater than 0.1 were pooled in a small centrifuge tube. The volume in each 
tube was measured with a small glass cylinder and used for further yield calculations. 
The absorbance of each tube of pooled fractions was taken three times at 280 nm. 800 
pi of Mannoside was used as a blank and for each measurement 200 pi of sample was 
then mixed with the 800 pi of Mannoside elution buffer to give a fivefold dilution. This 
ensured that the readings are within the most accurate range of the spectrophotometer. 
The average of three close readings was used to calculate concentration of purified 
protein for each flask. Finally, a wave-length scan at 250-300 nm was performed and 
the absorbance at 260 nm and 280 nm were read to calculate the A280/A260 ratio which if 
> 170 indicates the less contaminants like (nucleic acids, lipid, and carbohydrate 
molecules) and the purity more of the refolded protein.
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(a) Control
Columns Binding Columns Binding
Mops Refolding Buffer Mops Refolding Buffer
Mannopyranoside ElutionMannopyranoside ElutionMannopyranoside Elution
Additive+Columns Binding
Additive+ Mops Refolding Buffer
2 Inclusion bodies pellets -  6 m l 8M  Gnd-HCl
Guanidine Hydrochloride Extract
Figure 2.2 General schemes for an additive
Shows the practical steps used (a) Control is at 0.27 M Gnd-HCl concentration i.e. with no additions just 
the guanidine hydrochloride extract used at start to denature the protein, (b) Additive additions at the 
refolding stage, and (c) Additive additions before the binding to affinity chromatography columns or the 
after refolding stage.
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2.4.7 Yield Calculations
The final yield is expressed in milligrams per litre of growth culture (mg/1 culture), and 
is calculated as follows:
A280x0.877= mg/ml 
Mg/ml x 5  = Mg/5ml 
Mg/5mlx mls/tube = mg/tube 
Mg/tubex2 -  mg/1 culture 
Where:
A280 = absorbance at wave length 280.
0.877 = conversion factor of absorbance into milligrams per millilitre used.
5 = dilution factor used to ensure that the readings are within the most accurate range of 
the spectrophotometer.
Mls/tube = volume of the eluted protein fractions with absorbance readings greater than 
0 . 1  pooled in a small centrifuge tube.
Mg/tube = milligrams in 500 millilitre culture
2.4.8 Statistical Definitions Used
Definitions and formulae are given below:
For N observations of Xi values:
Mean (m) = (IXj)/N
Standard Error of the Mean (SEM) = S/V [N-l] =SN  [N]
Where:
S = standard deviation of the Mean 
S = standard deviation of small population size.
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Chapter Three
Results
3.1 Introduction
Recombinant proteins over expressed in E. coli face many challenges during refolding. 
Aggregation is the major cause of low yields that different studies have tried to 
overcome. The present project is trying to improve the refolding renaturation yields by 
introducing some additives like glycerol, guanidine hydrochloride (Gnd-HCl), and 
Triton X-100. Moreover, optimise the refolding incubation temperature and dilution 
protocols. A general scheme of the different experiments used illustrated in Figure 2.2 
provides the main idea followed using the different additives. In addition, Figures 3.1 
and 3.3 explain the processing scheme for the high-level expression of the protein 
model Con A.
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H iah-level e x p re ss io n  rec o m b in an t C on A:
F in a lvcoaen> defic ien t (m utant) h o s t s tra in  (► a lv c o a e n  e lim in a ted )!
OR
in b ac te ria  g row n  w ithou t a lu c o se  (► a lv c o a e n  m inim ised)
Celf Ivsis & w ash in a  reafm e (so n ica tio n /cen trifu aa tio n ). e.o .:
Borate-EDTA-Triton buffer > Borate-EDTA buffer > w ater
{ recom binan t C on A in so lu b le  in pe lle t -  reta ined ,
► a lv c o a e n  re le ase d  ( -b o ra te )  + o th e r  so lu b le  co n tam in an ts  — d isc a rd ed )
IL * >
S o lid s d isso lv ed  in Guanfdine-HCI
{rec. Con A + o th e r  p ro te in s  d en a tu re d  — so lub le ,
► residua) g lycogen , e tc . so lu b le )
P ro te in  refo ld ina reaim e: buffer d ilu tion, ad d itiv es , tem p era tu re , tim e
{active rec . Con A + o th e r  im purities — so lub le ,
► residua l a lv co a en  b in d s, com plex  p rec ip ita tes  + 
m is-fo lded  p ro te in s  a a a re a a te : p rec ip ita te  ce n tr ifu ae d  — d isc a rd e d )
W s |>
S olu tion  applied  to  D exfran affinitv co lum n
(ac tive  rec . C on  A b inds so ec ifica llv  — reta ined , 
inac tive  C on A, o th e r  p ro te in s , e tc . w a sh  th ro u g h  — d isc a rd ed )
o  !*#>
B iosoecific  elu tion  w ith a -M e-m annoovranoslde
(ac tiv e  rec. Con A soecificallv  re le a se d  — co llec ted )
A nalvsis fo r aua litv  an d  auan titv : 
e lu tion  profile, UV-Abs., SDS-PAGE, m a s s  sp e c .,  ca rb o h y d ra te  a s s a y s
(so lu b le  ac tiv e  rec. C on A — pure. ► a lv c o a e n  & o th e r  im purities — a b se n t)
Figure 3.1 Schem e for preferred em bodim ent m ethod for the purification o f Con A
Purification method for a recombinant glucose binding protein. Reproduced with permission from Jones, 
H., (2005). W 020051987.Patent.
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Growth and cell harvest 
▼
Cell disruption and inclusion body isolation
Cell contaminants
Differential centrifugation
Inclusion body washing
Solubilisation of inclusion bodies
Refolding
Further purification
m
Figure 3.2 The Purification Scheme of Inclusion Bodies In This Laboratory
Illustrating the purification scheme o f  inclusion bodies over expressed in e-coli used in our laboratory.
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3.1.1 Glycerol
3.1.1.1 Introduction
The present study targeted protein aggregation as one of the major reasons for yield 
reduction by introducing glycerol as one of the refolding aids (see sectionl.4.7.2) to 
control the effect produced by hydrophobic interactions. It was stated that dilution or 
dialysis techniques of the refolding of dissolved inclusion body proteins result in 
aggregated folding intermediates mainly caused by hydrophobic interactions (Fan-Guo 
et al., 2001). Although purified inclusion bodies provided a tool in the improvement of 
in vitro refolded protein yield (Rattenholl et al., 2001) and (Nashihara et al., 2000) 
artificial chaperones (chemical aids) have been introduced to assist in protein refolding 
(Fan-Guo et al., 2001) and (Kumar et al., 1998).
3.1.1.2 Method
In the current study glycerol was used as a co-solvent additive, at concentrations of 0, 1, 
2, 5, and 10 % (v/v) (Figure2.2) to investigate its effects on the folding process. Because 
this additive will also remain during column loading, its effects on folding alone may be 
masked by any additional effects on affinity binding. Thus, in order to determine 
possible direct effects of glycerol on the binding of active protein to the dextran matrix, 
further experiments were also conducted in which glycerol was added only after the 
refolding stage. The terms “refolding” or “binding” were determined by the addition of 
glycerol either at the start of the refolding process or just before loading of the already 
refolded buffer onto Sephadex G-75 chromatography columns, respectively. So, here as 
in the general method (refer to section 2.4.5) harvested bacterial inclusion bodies as 
solid pellets were processed mechanically, washed for optimum purification and 
solubilised by 8 M chaotropic guanidine hydrochloride. Refolding was then carried out 
by rapidly diluting the 6  ml guanidine denatured extract 30-fold, as aggregate formation 
is highly protein concentration-dependent, into ice cold MOPS refolding buffer. At this 
stage the concentration of guanidine hydrochloride normally present is 0.27M. The 
refolded extract was then kept on ice for 1 hour, at room temperature for another hour 
then loaded onto a chromatography column of Sephadex G-75 after being subjected to 
centrifugation. After being loaded for approximately 18 h pure protein was then eluted
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with 10 mM Methyl-a, D-Mannopyranoside in MOPS metals buffer. A part of the study 
used glycerol as an eluant then continued to use the normal elution buffer as previously 
mentioned. The quality of the purified protein was then confirmed by sharp elution 
profiles and spectroscopic wavelength scans.
3.1.1.3 Results and Discussion
To block aggregation in the refolding solutions (Table 3.1) indicates the effect of 
different concentrations of glycerol on the refolding and dextran-binding stages of Con 
A purification, (a) The refolding stage indicates concomitant reduction in yields with 
the increase in glycerol concentrations as 1 0 % glycerol scored the lowest yield. 
(b)Another experiment was conducted using glycerol at 5% and 10% before the binding 
to the dextran in an attempt to further explore the effect of glycerol on the binding stage 
indicated decreased amounts of yield with 10% glycerol concentration as the lowest. In 
a comparison between (a) and (b) parts of (Table 3.1), and (Figure 3.3), it was found 
that: 5% glycerol concentration indicated a decrease of 29% at the binding stage to the 
dextran compared to the refolding stage. Moreover, 10% glycerol also showed a 
decrease of 8.7% at the binding stage compared to the refolding stage (comparison 
attempted with data having the same control sets). In addition, the elution process was 
investigated to exploit the effect of glycerol on it by introducing (5% and 10%) as 
elution buffers instead of methyl- a -D-mannopyranoside, which is the current eluant 
used (Larson, et al., 1994). However, the yield was insignificant as (Figure.3.4): 
indicated that glycerol has no significant effect on the elution of the lectin manifested by 
the small peak of the profile compared to control. However, (Figure.3.5); shows the 
elution profile and yield when the same sample eluted for the second time with methyl- 
oc-D-mannopyranoside. Glycerol has produced a negative effect on the refolding stage 
starting from 1% and to the lowest yield at 10%. Although, scientists like (Meng. et al., 
2 0 0 1 ) have considered glycerol as one of the most effective additives on the prevention 
of aggregation and that 1 0 % glycerol was found to be the optimum percentage that 
completely prevent aggregate formation. The comparison between the two parts of 
(Table 3.1) and (Figure 3.3); implies that certain amount of purified con A was lost 
some where between refolding and elution. This means that glycerol doesn’t improve 
the refolding of Con A as expected since it reduces the yield when used during the
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refolding stage, and at the same time severely affect the binding of the lectin to the 
dextran. Before, the work of different research groups (Charron et al., 2002; 
Derewenda et al., 1989; and Jain et al., 2001a)) indicated (Figure3.6) that glycerol 
displaces water molecules at certain sites (G1 and G2) of the four subunits of the Con A 
molecule. However, the interesting part is that glycerol does not just displace water but 
a recognition phenomenon arises where G1 interacts with participating residues in 
carbohydrate recognition (Asnl4, Leu99, Asp208 and Arg228). Moreover, the glycerol 
at G4 interacts with Asn44 and Ser201 (peptide recognition), and also involved in the 
interaction with 15-mer and 10-mer peptides. Therefore, and as a conclusion to the 
previously mentioned Lopez-Jaramillo, et al., (2004) has argued that: the fact that the 
G2 site is occupied by a molecule of glycerol in the four monomers of the asymmetric 
unit support the observations that G2 is playing a vital role in the binding/recognition of 
ligands. These reports confirm that glycerol affects the binding of the lectin to dextran 
which agrees with the current study results. Further, the disappointing result of the use 
of glycerol as an eluant also explained that Con A is more susceptible to methyl-oc-D- 
mannopyranoside than glycerol. And lead to the assumption that glycerol compete for 
the carbohydrate binding site with methyl-oc-D-mannopyranoside making Con A less 
available for elution and, hence, purification. As a conclusion glycerol in this study 
added an insight to the problem concerning its ability to affect the saccharide binding 
sites of the lectin.
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Glycerol 
concentration 
% (v/v) added 
at stage:
(a)
Refolding
(b)
Binding
Yield (mg/1) A 280/A 260 Relative
Yield%
Yield (mg/1) A 280/A 260 Relative
Yield%
0
14.1,16.3,14.6,
13.9
M =  14.8 
SEM =0.55
1.8,1.8,1.9, 
1.9
100 14.1,16.3,14.6,
13.9
M =  14.8 
SEM  =0.55
1.8,1.8,1.9, 
1.9
100
1 15.6,12.8, 10.9 
Mean = 13.1 
SEM = 1.67
1.9,1.8, 
2.0
88.5 Not
Determined
2 11.2 1.9 75.7 Not
Determined
— —
5 11.6 1.9 78.4 7.3 1.9 49.3
10
5.0, 5.1, 6.6 
Mean = 5.6
1.8,
1.9
37.8 4.3 2.0 29.1
Table 3.1 The effect of varying glycerol concentrations on the refolding and dextran-binding stages 
of Con A purification
The control data (0% glycerol) were also shown in italics for the binding stage. The refolding part o f  the 
table indicates a decrease o f  11.35, 24.07, 21.36, and 62.24% according to the percentages o f  glycerol 
added respectively. Moreover, the after refolding or before binding to the dextran part focuses on the 
great fall in the yield to 70.85% from control at 10% glycerol.
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0.4
0.2
0
0.89
0.76 0.78
0.49
□ Refolding 
i  Binding
□ Control
0% 1% 1% S% 10%
Figure 3.3 Glycerol concentrations (%) added at refolding and binding stages
Shows the relative yield when adding glycerol at 1, 2, 5 and 10 % (v/v) during the refolding stage th Q  
after refolding or before binding to the dextran H  o f  Con Apurification. Control data (0% glycerol) 
illustrated L_(white) in the figure. The decrease in yield is clear at the refolding stages, while it is vividly  
clear at the binding stage with 10% indicating the lowest.
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Control Elution
Glycerol Elutions
€s>fi; ho, sg-rsMi i<f 7888-0?
Figure 3.4 Elution profiles using 5% and 10% glycerol concentrations
Shows elution profiles when 5% and 10% glycerol concentrations where used as eluants in place o f  
methyl-oc-D-mannopyranoside the usual eluant. Small peaks indicate no purified proteins were eluted 
compared to the control shown above.
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Control Elution
Mannopyranoside
Elutions
C a d e  No.
Figure 3.5 Elution profiles using methyl-oc-D-mannopyranoside
Shows the same samples o f  Figure 3.5 eluted again with methyl-oc-D-mannopyranoside. The obvious 
peaks indicate the elution o f  some purified Con A. However when compared to control there is some 
protein that is still bound to the columns.
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EU 99 N
WR 100 N 
T IP  725 OH:
TVR 100 N
T IP  725
5 02 5 02
ISP 208 001 ISP 208 001
03
IRG 228 N IRG 228 N
ND2ISNIP 208 002 'HSP 208 002
14 )D1
Figure 3.6 Stereo-view of the niFo y Fc map omit map contoured at 5
Shows the glycerol molecule at G l was not included in the calculation. Residues involved in 
carbohydrate recognition and that form hydrogen bonds to the glycerol are labeled. Figure adapted from 
(Lo pez-Jaramillo et al., 2004). Acta Cryst. D60, 1048-1056.
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3.1.2 Guanidine Hydrochloride
3.1.2.1 Introduction
Aggregation is a major problem in reducing the refolding yields, thus, the main goals of 
the current studies were to find a solution to overcome this barrier. Guanidine 
hydrochloride (Gnd-HCl) as a denaturant in high concentration (8M) is used extensively 
as part of the isolation and solubilisation process of the insoluble inclusion bodies 
harvested as bacterial fermentation pellets (refer to section.2.4.5). Some studies 
indicated the use of this denaturant to reduce the possible formation of aggregates by 
using it in low concentration, (refer to section 1.4.7.1). Therefore, this current section 
focused on Gnd-HCL as a refolding aid to improve the overall yield by diluting the 
primary (8M) Gnd-HCL concentration to (0.27M) which is the refolding concentration 
currently used in our laboratory. Another trial is also conducted by raising the current 
Gnd-HCL concentration of (0.27M) during refolding and binding stages to (0.5M). One 
of the main aims of the current study was to find a suitable Gnd-HCl concentration 
which can aid the refolding yield to the maximum point and at the same time not affect 
the binding of the lectin to the dextran affinity matrix.
3.1.2.2 Method
The general method (refer to section 2.4.5) indicated that the initial guanidine 
hydrochloride concentration present at the start of the refolding process is 0.27 M 
following the inclusion pellet purification and solubilisation with 8M chaotropic 
guanidine hydrochloride. The conditions of refolding in the present part were altered by 
increasing the guanidine-HCl concentrations to 0.5, 0.75, 1.0 and 1.5 M. Figure 3.8 
describes the practical scheme used in the design of this section. Furthermore, the 
effects of guanidine-HCl on binding of active lectin to dextran were also separately 
assessed so that its usefulness as a folding aid could be determined. The quality of the 
purified protein was confirmed by sharp elution profiles and spectroscopic wavelength 
scans. Mean and standard errors of the mean were calculated where applicable.
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(a) Control
Centrifugation
Mops Refolding Buffer Mops Refolding Buffer
Marmopyranoside Elution Mannopyraooside ElutionMarmopyranoside Elution
Extra Gdn-HCl -Columns Binding
Extra Gdn-HCH- Mops Refolding Buffer
2 Inclusion bodies pellets -t- 6 ml SM Gnd-HCl
Guanidine Hydrochloride Extract
Figure 3.7 Practical steps used in the guanidine hydrochloride study
Shows (a) Control is at 0.27 M Gnd-HCl concentration i.e. without any additions just the guanidine 
hydrochloride extract used at start to denature the protein, (b) Illustrates the refolding stage with extra- 
Gnd-HCl, and (c) the binding to the column or the after the refolding stage with extra-Gnd-HCl.
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3.1.2.3 Results and Discussion
In this series of experiments (sets of four conditions) guanidine-HCl at concentrations 
of 0.27, 0.5, 0.75, 1.0 and 1.5 M was investigated during the refolding and binding 
stages, (Table 3. 2) the first experiment (a) investigated the effect of guanidine 
hydrochloride at the binding stage. This indicated a small decrease in the purified yield 
compared to the control when guanidine hydrochloride was used at 0.5 M and this result 
was confirmed by a similar repeat (b). However, experiment (a) produced a clear 
decrease in binding when guanidine hydrochloride was used at 1.0 and 1.5 M. 
Experiment (b) also indicated a clear decrease in yield when guanidine hydrochloride 
was used at 1.0 and 1.5 M during the refolding stage, (Table 3.2) and (Figure 3.8). 
Therefore, the effect of guanidine at concentrations less than 1.0 M was investigated in 
more detail. In addition, two more experiments (c and d) have been conducted with 
guanidine hydrochloride at 0.5 and 0.75 M during the refolding or binding stages, 
(Figure 3.19). A distinct increase of 1.23-fold (23 %) in yield compared with the normal 
procedure (control) is found when 0.5 M guanidine is present during protein refolding. 
In contrast, there is no noticeable effect (1.0-fold) of 0.5 M guanidine on dextran 
binding, and a binding decrease (0.78-fold) with 0.75 M. The mean and standard error 
of the mean indicate the precision of the methods used. The study has found a new 
thread to follow by adopting the 0.5M Gnd-HCl procedure during refolding in further 
studies where this concentration lead to greater yields and does not interfere in the 
binding stage. As a result of the above mentioned it is found that the folding/unfolding 
process is a complicated not a straight forward issue that proceed through more than one 
stage. The use of Gnd-HCl at 8 M completely unfolds Con A while diluting to 0.27 M 
allows for refolding. Raising the concentration to 0.5 M permits more refolding to form 
the native protein, since it can prevent the aggregation to some extent and this result is 
consistent with the studies reported by (West et al., 1998), about the refolding of 
carbonic anhydrase and the formation of intermediates and then the native state using 
0.23M and 0.6M Gnd-HCL concentration.
77
Guanidine 
-HC1 (M)
Refolding Binding
added at
stage: Yield (mg/1 A 280/A 260 Yield (mg/1 A 280/A 260 Relative
culture) Relative culture) Yield %
Yield %
22.2a,18.7b 1.8a, 22.2°, 18.7b, 1.8°,
16.3C, 20.3d 1.9b 16.3C,20.3d 1.9?
23.9C, 23.1°, 1.8° ,2 3 .9 c, 23.1c, 1.8°
0.27 24.8d 2.4d 24.3d 2.4d
(normal
p<NIIs 2 .0C, M  = 21.0 2.or,
method) SEM =1.15 1.8°, SEM  =1.15 1.8?,
1.8d 100 1.8? 100
20.6C, 26.3d 1.9°, 2.0d, 20.1a,17.4b 2.3a,
27.9°, 26.T , 1.9°, 17.5C, 21.1°, 1.9b, 1.9°,
27.9d 1.7c,1.9d 25.9°, 2 4 .l d 2.2c,1.9c4d
0.5 M = 25.9 123.3 M =21.0 100
SEM=1.36 SEM=1.41
15.0C,18.3d 2.2°
0.75 Not Not Not
\6lls 2 .0d
Determined Determined Determi 78.1
ned
1.0 10.0b 1.9b 47.6 11.7a 1.8“ 55.7
1.5 12.6b 1.8b 60.0 12.6a 1.8a 60.0
Table 3.2 Effect of Gnd-HCl concentration on the refolding and binding stages
Control sets were conducted at the 0.27M  Gnd-HCl concentration refolding also shown in italics for the 
binding stage. The table indicates an increase o f  23.3% in the yield at 0.5 M (refolding) compared with the 
control during experiments (c and d). Superscript letters (a, b, c, and d) describing the same set o f  
experiments. M= mean, and SEM= standard error o f  the mean.
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1.4
1.2
c
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0 O .8
2v
a; 0.6 
22
£0 .4
0.2
1.23
0.48
□  control 0.27M 
0.6 D0.5M
□  1.0,VI
□  1.5M
control 0.5 1.0 1.5
Figure 3.8 G uanidine-HCl Concentration (M) during refolding
Indicates the increase o f 23%  in yield when Gnd-HCl was added at 0.5 M g  during refolding with 
significant decrease o f 52% and 40%  at 1M □  and 1.5 M B  , respectively. Control □  concentration is 
0.27 M. All data in Table 3.2 used to plot this Figure.
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1 .4
1.2
1
0.8
0.6
0.4
0.2
0
control
1.23
refolding
0.5M
binding
0.5M
0.78
binding
0.75M
□ control 0.27M
□ refolding 0.5 M
□ binding0.5M 
0  binding0.75M
Figure 3.9 G uanidine-HCl Concentration (M) during refolding and binding stages
Shows relative yield o f  purified Con A (data o f  experiments c and d only) o f  Table 3.2 Control □  was 
conducted at 0.27M  Gnd-HCL concentration. An increase o f  23%  is indicated at 0.5 M □  refolding, no 
increase at 0.5M binding □  and a decrease o f  22%  at 0.75 M □  binding were observed, respectively.
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3.1.3 Dilution
3.1.3.1 Introduction
Dilution was considered as an inexpensive method that can prevent aggregation easily 
by just pouring the denaturant solution into a suitable refolding buffer (refer to section 
1.4.2). The method was extensively used in our laboratory where a previous study had 
exploited two dilution factors (30- and 60- fold). The aim of this project is to optimise 
the refolding conditions by finding a suitable refolding environment that assures the 
production of high renaturation yields. Therefore, picking up the best dilution factor 
which suits the refolding of Con A is one of these conditions. Dilution was explored by 
using most of the known protocols like rapid dilution, continuous dilution, pulse 
dilution and step-wise additions. It is worth mentioning here that mixing is a very 
important matter in aiding refolding and is greatly associated with dilution (section 
1.4.4). Unfortunately, no separate data were available to reveal its value in refolding; 
however, it has been used extensively in the present refolding studies.
3.1.3.2 Method
The general method stated the practical stages used (refer to section 2.4.5), however, 
some alterations in the refolding conditions were made in the current sets of 
experiments. Different rapid dilution factors ranging from 15 fold to 120 fold were 
investigated using a final Gnd-HCL concentration of 0.5M (conducted by just pouring 
the denaturant mixture into Mops refolding buffer). Furthermore, other dilution 
protocols were also explored like continuous dilution where the denaturant solution was 
added continuously in a drop-wise manner over 1 hour of ice incubation using an 
automatic pipette to a final Gnd-HCl concentration of either 0.27 or 0.5M. Pulse 
renaturation protocol was performed by adding portions 6/12= 0.5 ml of the denaturant 
solution at timed intervals (every 1 0  minutes) during 2  hours of ice incubation to a final 
Gnd-HCl concentration of 0.5M. Lastly, the step-wise dilution which is a technique 
using the rapid dilution method but is carried out by keeping certain time intervals 
between additions over 1 hour. Two experiments were conducted at different dilution 
factors 30 fold (3X then after lA hour 10X) and 15 fold (3X then after lA hours 5X) 
aiming towards a final Gnd-HCL concentration of 0.5M. Control sets for the different
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experiments were using the rapid dilution method at both Gnd-HCL concentrations 
(0.27 or 0.5 M). Absorbance ratios of A280/A260 confirm the quality of the purified 
protein. Means and standard errors were also calculated where applicable.
3.1.3.3 Results and Discussion
The aim of the current series of studies as was mentioned above was to tackle 
aggregation by either preventing or reducing its formation. Most of the documented 
literature has focused on the elimination of aggregation by reducing the protein 
concentration depending on the existence of a strong relationship between protein 
concentration and the presence of aggregates, thus, insisting that the prevention of the 
competition between aggregations and refolding is a vital matter. Therefore, here in this 
section the various dilution protocols like rapid, continuous, pulse, and step-wise 
additions using two guanidine-HCl concentrations of 0.27 and 0.5 M (where applicable) 
were deeply investigated. Firstly, a study illustrating the effect of different rapid 
dilution factors on the refolding of Con A was conducted. Table 3.3 and Figure 3.10 
compare the relative yields at different dilution factors (15X -120X). As a result, 
dilution factor 30 fold at 0.5M concentration appeared as the optimum factor, since, an 
increase of 14% to the control has been recorded and the quality of the protein 
represented by the A280/A260 ratios was good. Furthermore, (Figure 3.11) indicates a 
relationship between the protein concentration and the renaturation yields. If it is 
assumed that the control refolds all the protein present so that 27.3 mg/1 culture 
corresponds to the total concentration of Con A, this may be converted to concentration 
in pg/ml that would be present in the 180 ml in the refolding flask at 3OX dilution. Then 
the concentration of Con A at 15X is twice this, concentration at 60X is half this, etc. 
The bell-shaped curve shows the type of relationship found.
Secondly, another study investigated the role played by different dilution protocols on 
the prevention of aggregate formation (Table 3.4 and Figure 3.12) compared between 
controls (rapid dilution), continuous, pulse, and step- wise additions. Continuous 
renaturation at (0.5M) Gnd-HCl concentration has shown an increase of 10% during 1 
hour of ice incubation whereas the pulse renaturation method indicated a decrease of 
23% when incubated for 2 hours. On the other hand, there is a negligible decrease of 3% 
when continuous renaturation was compared to control at (0.27M) during 1 hour of ice
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incubation. Figures (3.13 and 3.14) show the gradual increase in the Gnd-HCl 
concentration during the two protocols used (the continuous dilution and the pulse 
renaturation method). The striking feature in this study was the very low yield obtained 
using the step-wise dilution (Table 3.4) that clearly indicated the presence of aggregates 
by the obvious turbidity (a visual observation) of the refolding mixtures when compared 
to the controls. This result implied that the starting high concentration of both the 
denaturant and the protein (Table 3.5) with an initial protein and denaturant 
concentration of 620pg/ml and 2.9 M respectively was the main cause of aggregation. 
Thus, the step-wise method is not one of the favoured ways for the refolding of Con A. 
(Terashima et al., 1996) reported that the rate by which the denaturant should be added 
to the refolding buffer must be slower than the rate determining the folding step for the 
protein to prevent aggregation. The rapid dilution protocol results indicate the crucial 
role played by the Gnd-HCl concentration and the volume of the refolding buffer 
solution when the start point was at high concentration of both Gnd-HCl and the 
protein. The occurrence of sudden low Gnd-HCl concentration during the first part of 
the refolding process enable formation of the first partly folded forms and the diluted 
protein concentration favours the prevention of aggregates. (Figure 3.15) indicates a 
hypothetical pathway describing the events of the formation of a native soluble active 
tetramer of Con A when starting at high Gnd-HCl and protein concentrations since 
aggregation at high protein concentrations leads to low yields. However, low protein 
concentration also reduces the yields as seen in Figures (3.10 and 3.11). (Figure 3.15) 
suggests also that the formation of an unstable monomer is the determining factor for 
successful refolding as it cannot fold independently before associating but needs a 
partner at an early stage of the refolding process to form a dimer. (Figure 3.15) can 
represent all sorts of other dilution protocols in addition to the rapid dilution method. 
These ideas are also illustrated in (Figure 3.16).
To conclude with, high protein concentration reduces the overall refolding yields due to 
the formation of aggregates. However, very low protein concentrations can lead also to 
other problems where the possible difficulty for the monomer to find a partner also 
reduces yields. The presence of a stable monomer would lead to fully folded dimer as it 
is less sensitive to dilution and with unlimited time to find a partner. Tetramer is then 
formed at the end of the process by the reversible association of fully folded dimers. On 
the contrary, the unstable monomer is very sensitive to its environment and without 
finding a partner in a limited time it may become part of an aggregate or otherwise
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misfold. This misfolded monomer might be another inactive but soluble form of 
monomer that is unable due to its altered structure to bind to a partner and form a 
partially folded dimer. The critical element of this scheme is the suggestion that Con A 
is more likely to fold via the formation of dimers early in the process so that unstable 
monomers are recruited into more stable dimers rather than being able to fold in 
isolation as stable monomers. If there is a limited time for an unstable subunit to find a 
similar partner before it becomes unable to bind it, then low protein concentrations will 
discourage correct folding. In other words, it is proposed that early dimer formation is 
essential for folding to proceed correctly, rather than that late dimerisation occurs after 
the correct folding of isolated monomers is complete.
The accurate determination of the appearance of the hypothetical partially folded 
unstable monomer might open a new door for refolding in industry. This work might 
help overcome the barriers when refolding by dilution through suggesting economical 
ways to control the refolding buffer volumes and the equipment needed for the process.
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DILUTION  
FACTOR (X)
Yield  
(mg/1 culture) A 280/A 260 Relative Yield %
15
14.3a 
17.3b 
18.8C 
M =  16.8 
SEM = 1.32
2.3a
1.9b
2.0C
61.5
20 22.8d 2.2d 83.5
30
28.0a 
26.7b 
27.9C 
26.6d 
M = 27.3 
SEM = 0.45
1.9a
1.8b
1.8°
2.3d
100
60
25.5°, 24.6d 
M = 25.1
1.7°
2.3d
91.9
120 19.l d 1.3d 70.0
Table 3.3 The effect of rapid dilution factors on the refolding stage at 0.5 M Guanidine HC1
Table shows the effect o f  different dilution factors at 0.5 M Gnd-HCl on the overall refolding yield. 
Dilution factor 30X giving the optimum yield mean=27.28 ±  0.45. Superscript letters a, b, c, and d 
indicates a specific experiment with the purity o f  examined sample shown by corresponding absorbance 
ratio.
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□ c o n t r o l
control 60X 120X
Figure 3.10 Effect o f different (rapid) dilution factors on the refolding stage of Con A
Describes the effect o f different dilution factors on the refolding stage o f  Con A at 0.5M Gnd-HCl 
concentration. Histogram shows an approxim ate bell shape where, Control sets □  at dilution factor 30X 
show maxim um  yield, and sets o f  dilution factor □  15X indicate the minimum. Figure used data from 
Table 3.3.
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Figure 3.11 Effect of protein concentration on the renaturation yield 
(At 0.5M Gnd-HCl concentration using rapid dilution)
Relates the protein concentration to the overall renaturation yield when refolding at 0.5M  Gnd-HCl final 
concentration and using the rapid dilution method. The bell shape curve indicates the optimum protein 
concentration as 80 pg/ml according to 27.3 mg/1 culture yield. Protein concentrations <50 pg/ml 
provides lower renaturation yields.
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Dilution Protocol
Refolding over 3 - 4  hours:
Gnd-HCl
concentr
ation
Rapid Dilution 
(30X) (Control)
1 hour on ice,
2 hours on bench
Continuous 
dilution 
(< 3 OX)
During 1 hour on 
ice,
2 hours on bench
Pulse dilution 
(< 3 OX)
During 2 hours on 
ice, 2 hours on 
bench
Step dilution
(3X, 30 min then
10x)
1 hour on ice,
2 hours on bench
Step dilution 
(3x, 30 min then 
5x)
1 hour on ice,
2 hours on bench
Yield
(mg/1
culture)
A 280/
A260
Yield
(mg/1
culture)
A28
0/A2
60
Yield
(mg/1
culture)
A 280/
A260
Yield
(mg/1
culture)
A 280/
A 260
Yield
(mg/1
culture)
A 280/
A260
(0.5M)
Gnd-
HCL
24.5
21.5
21.6  
M =22.5 
SEM= 
0.98
2.2
1.9
3.0
21.6
26.2
24.4
22.0
M =23.6
SEM=
1.08
3.0
1.9
1.8
1.7
17.5 2.1 2.0 4.1 0.5 3.2
(0.27M )
Gnd-
HCL
22.2 1.8 22.6
21.0
M =21.8
1.7
2.9
Not
Determin
ed
- Not
Determin
ed
- Not
Determi
ned
-
Table 3.4 Effect of different dilution protocols on the refolding stage 
(At (0.27 and 0.5) M guanidine -HC1 concentrations)
Results o f  the different dilution protocols using 0.27 and 0.5 M Gnd-HCl final concentrations over 1 - 2  
hours ice incubation. The table compares controls, continuous, pulse and / or step- wise dilution, where 
continuous renaturation (0.5M ) is showing an increase o f  10% after ice incubation for 1 hour with a pulse 
dilution decrease o f  23% when incubated for 2 hours. On the other hand, there is a negligible decrease o f  
3% when continuous renaturation was compared to control at 0.27M  with 1 hour ice incubation. Step 
dilution in dilutions (3*, 30 min then 10x) or (3x, 30 min then 5x) shown the least yields o f  all, where 
much greater turbidity o f  buffer solutions was the dominant feature (visual observation). Mean (M) and 
Standard Error o f  the Mean (SEM) indicated where applicable.
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Figure 3.12 Effect o f various dilution protocols on the refolding stage of Con A
Illustrates the effect o f  different dilution protocols on the refolding stage at two Gnd-HCl concentrations 
(0.27 and 0.5) M. control sets are rapid dilution at factor (30X). Continuous dilution □  during 1 hour and 
at 0.5M Gnd-HCl level indicates the highest refolding yield. Figure used data from Table 3.4.
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Figure 3.13 Gnd-HCl concentration during 1 hour ice incubation period of the refolding process 
(Using continuous dilution protocol)
Shows the gradual increase in Gnd-HCl concentration from an initial concentration o f  4 .4x10-3 to a final 
concentration o f  0.27M. Additions were determined as drop sizes o f  ~0.1ml/min. and refolding buffer 
volume =180 mis. Based on Data taken from Table 3.4.
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Figure 3.14 Gnd-HCl concentration during 2 hrs ice incubation period of the refolding process 
(using pulse dilution protocol)
Shows the gradual increase o f  Gnd-HCl concentration to final concentration o f  0.5M during the 2 hours 
ice incubation indicating an initial refolding buffer concentration o f  Gnd-HCl = 0.23M. Additions o f  
Denaturant solution are timed by every 10 min. with drop size = 0.5ml/10min. Hence, denaturant 
concentration of~0.023M  is added every 10 min. Based on Data taken from Table 3.4.
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Protocol Control 
(Rapid Dilution)
Step dilution 
(3x,30min.then 10x)
Step dilution 
(3x,30min.then 5x)
Initial
Concentration
Final
Concentration
Initial
Concentration
Final
Concentration
Initial
Concentration
Final
Concentration
Protein
Concentration
(pg/ml)
62 62 620 62 620 124
Denaturant
Concentration
(M)
0.5 0.5 2.9 0.5 2.9 1.0
Table 3.5 Denaturant and protein concentrations during 1 hour ice incubation stage of the step 
dilution
Indicates the Initial and final protein and denaturant concentrations. Control at 0.5M  Gnd-HCl 
concentration and conducted using the rapid dilution method (1 hour on ice, 2 hours on bench). Step 
Dilution 30X and Step Dilution 15X started both with initial protein and denaturant concentrations o f  
620|ig/m l and 2.9M  respectively. Based on Data taken from Table 3.4.
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Figure 3.15 Hypothetical pathway of the effect of dilution on the formation of native Con A 
tetramer
Shows the effect o f  varying concentrations o f  Gnd-HCl and protein on the formation o f  biologically  
active Con A  and also aggregates.
The presence o f  the partially folded unstable monomer in favourable refolding conditions is assumed to 
determine the success o f  the renaturation process.
1-Stable monomer association is less sensitive to dilution since unlimited time to find partner.
2-Unstable monomer association is more sensitive to dilution since limited time to find partner to 
continue folding successfully.
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Figure 3.16 Hypothetical events during the refolding of Con A
Shows three hypothetical events during the refolding o f  Con A  relating to Figure 3.16, where Aggregation 
here comprises the right-hand side: partially folded unstable monomer leads to aggregates at high protein 
concentrations. Expected represents the association 1 pathway where fully folded monomer as a stable 
intermediate gives rise to fully folded dimer. Actual represents Association 2 pathway where the 
formation o f  a partially folded dimer by an unstable monomer is more sensitive to lowered protein 
concentration.
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3.1.5 Temperature
3.1.5.1 Introduction
The present study concentrated on the role of incubation temperature during the 
refolding stage as a potential factor in optimising the refolding conditions. As the goal 
for the whole project is the production of improved yields by preventing the aggregation 
process, temperature was found to play a leading role in this aspect (Section 1.4.6) The 
current protocol of methodology used in the laboratory (section 2.4.5) always maintain 
the refolding solution at 0 °C (ice incubation) then a warming up step by allowing 
standing on bench temperature incubation (this, however, depends on the season of the 
year whether it is warm or cool). This part will try to explore the various temperatures 
and their effects on the refolding and binding stages and the role which is played by 
them in reducing the aggregation process. Furthermore, observations are made at two 
different Gnd-HCl concentrations combined with the incubation temperatures on the 
refolding process.
3.1.5.2 Methods
The general method (refer to sec.2.4.5) indicates that the initial guanidine hydrochloride 
concentration present during the refolding process is 0.27 M. The present study 
investigated the role of the refolding incubation temperature by changing the design of 
the general refolding experiments as follows: (a) refolding over 3 hours using constant 
temperatures of -5.5, 0, 4, 15, 25, or 37°C through out the refolding process, (b) 
Refolding over 3 hours: that is 2 hours ice incubation and 1 hour at 0, 4, 15, or 25°C. 
The control refolding conditions for both (a) and (b) were; 2 hours on ice and 1 hour 
standing on the bench. Temperatures were maintained as follows: 15, 25, or 37 °C by 
using constant temperature water baths, 0°C by using an ice bath, 4°C by using the 
constant temperature cold room, and finally -5.5°C by using an ice-salt bath (a mixture 
of ice and 5% w/w sodium chloride) as the salt causes the mixture to absorb more 
energy from the environment (becoming colder). The -5.5°C condition was considered 
the lowest practicable temperature to reach before the freezing point of the Gnd-HCl 
refolding buffer (-7.4°C). The Gnd-HCL concentration in this study is at 0.5M and the 
quality of protein purified is measured with the absorbance ratios of (A280/A260)
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3.1.5.3 Results and Discussion
The current study aimed at the prevention of aggregation through the control of the 
incubation temperature during the refolding stage. Several temperatures were selected 
for trial so as to optimise the refolding conditions. (Table 3.6) indicates the design of 
two experimental sets, the first was conducted by using constant selected temperatures 
of -5.5, 0, 4, 15, 25, or 37°C over 3 hours of the refolding stage, the second was 
conducted in the normal way i.e., 2  hours ice incubation and then 1 hour incubation at 
one of the previously mentioned temperatures. Part (a) of (Table 3.6) reports decreases 
of 15.9, 54.80, 45.34, 100, and 100 % at -5.5, 4, 15, 25, and 37°C, respectively, 
compared to control sets. Part (b) of (Table 3.6) also indicates decreases of 21.31, 
18.90, and 59.75 % at 4, 15, and 25°C compared to the control sets. However, 
comparisons between (a) and (b) indicates increases of 74.12, 48.38, and almost 100 % 
at 4, 15, and 25°C, respectively. This is similar to the findings of Wetlaufer and Xie 
(1996) that their temperature-leap technique (Figure 3.19) can improve yields compared 
to constant temperature incubation throughout. These workers also saw decreasing 
yields as temperatures were increased in their experiments (Figure 3.20). Refolding with 
continuous incubation at 0°C produced the maximum yield as shown in Figures (3.17 
and 3.18). However, subsequent re-appearance of turbidity of these 0°C refolded 
mixtures during affinity column loading was noticed and this indicated the presence of 
some further aggregation problems. Aggregation and precipitation during overnight 
affinity column loading threatens column blockage that can initiate leaking of 
chromatography columns and loss of refolded protein. Although, Yoshii et al. (2000) 
dismissed the use of low temperature as it slowed down the refolding process in their 
studies, this was not the case here as good yields were recovered at low temperatures. 
The present study agrees with them in that low temperatures have a definite role in the 
prevention of hydrophobic aggregation. So, for practical uses, a rise in temperature was 
found to be important for the prevention of precipitate formation during column loading 
and to eliminate this problem after refolding at 0°C. Therefore, a bench warm up step 
was adopted (allows for gradual warm up of refolding solutions from 0 to 10-13°C 
during 1 hour as measured with an electronic thermometer). The present study also used 
water baths to reach certain temperatures more quickly as shown in (Figure 3.18).
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However, the “on bench” incubation protocol allowed for the recovery of better 
renaturation yields because of the gradual increase in temperature when the flask is not 
immersed in a water bath. Refolding during 3 hours incubation at 25 and 37°C produced 
zero yields, high turbidity and large accumulations of precipitate showing the 
unfavourable effects of high temperatures on refolding. A low temperature at the early 
stages of folding may improve the monomer’s stability allowing more time for 
association into the dimer structure of Con A, as well as decreasing the hydrophobic 
interactions responsible for aggregate formation.
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(a)
Refolding
conditions
3 hour
continuous
incubation
at given
temperature
Yield
(mg/1
culture)
(A 280/
A 260)
Relative 
Yield %
(b)
Refolding 
conditions 
2 hours 
incubation 
on ice, then 
1 h at given  
temperature
Yield
(mg/1
culture)
(A28o/A 26o) Relative 
Yield %
Control 
2 hours on 
ice, 1 hour 
on bench
26.0, 27.6,
28.0, 25.1 
M= 26.7 
SEM -0.71
1.8, 
2.8, 
2..2, 
2.3
100 Control 
2 hours on 
ice, 1 hour 
on bench
26.0, 27.6,
28.0, 25.1 
M=26.7 
SEM —0.71
1.8,2.8, 
2..2, 2.3
100
-5.5°C 22.6, 22.2 
M = 22.4
2 .1 ,2 .1 83.9 -5.5°C Not
Determined
Not
Determined
Not
Determined
0°C 24.5 
29.0 
M =26.8
2.0
2.5
100.4 o ° c 24.5
29.0
M =  26.8
2.0
2.5
100.4
4°C 12.1 3.0 45.3 4°C 19.6, 22.4 
M= 21.0
2.7, 2.5 78.7
15°C 14.8, 14.5, 
14.5
M= 14.6 
SEM=0.02
1.8,
1.9, 2.1
54.5 15°C 23.0, 20.2 
M= 21.6
1.9, 2.3 80.9
25°C 0.0 0.0 25°C 12,10.4,
9.8
M= 10.7 
SEM=0.75
2.4, 2.0, 
2.5
40.1
37°C 0.0 - 0.0 37°C Not
Determined
Not
Determined
Not
Determined
Table 3.6 Refolding conditions at different incubation temperature sets
Shows the refolding conditions over 3 hours where (a) illustrates an incubation period o f  3 hours at given 
temperature and (b) a 2 hours incubation period on ice then 1 hour at given temperature. Control sets 
were conducted as 2 hours on ice incubation, and then 1 hour on bench temperature. No detectable yields 
were obtained when refolding at constant temperatures o f  25°C and 37°C, while 0°C produced the 
maximum yield. Refolding conditions o f  2 hours on ice incubation then 1 hour at the given temperature 
indicated 0°C as having the maximum yield and enhanced by 40.1% o f  the relative yield at 25°C  
compared to the control.
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Figure 3.17 Relative yields o f Con A after 3 hours of continuous incubation  
(At different temperatures)
Shows the relationship between the relative yields after 3 hours incubation at different constant 
temperatures. Controls were 2 hours ice incubation and 1 hour on bench incubation. 0°C gave 
approxim ately the same relative yield as the control while other tem peratures o f  -5.5, 4, and 15 °C had 
decreased relative yields o f  0.16, 0.55, and 0.45, respectively. Tem peratures o f  25°C and 37°C gave zero 
yields. Figure used data from Table 3.6, part (a).
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Figure 3.18 Relative Yields o f Con A after 2 hours o f Ice Incubation and 1 hour 
(At given tem peratures)
Shows the refolding incubation periods o f 2 hours on ice then 1 hour incubation at different given 
temperatures. Figure indicates the same relative yield for the 0°C and control, also between 4 and 15 °C 
with a decrease o f 20 % and 25°C with a decrease o f  60% com pared to the control. Figure used data from 
Table 3.6, part (b).
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Figure 3.19 Temperature-leap refolding of bovine carbonic anhydrase II 
(At high protein concentration (4.0 mg/mL), 1.00 M GdmCl)
The first 120 min o f  the refolding was carried out at 4°C; the sample was then transferred to a 36°C  
thermostated bath. Activity assays and turbidity measurements were made on separate portions o f  the 
same sample. Figure adapted from XIE Y., and WETLAUFER D. B., (1996). Protein Sci. 5: 517-523.
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Figure 3.20 Activity recovery at 150 min in a series of temperature-leap experiments 
(on bovine carbonic anhydrase II)
(As in the previous Figure), where the first 120 min refolding is conducted at the temperature plotted; the 
sample is then transferred to a 36°C thermostated bath and the activity assayed at 150 min. Figure adapted 
from XIE Y., and WETLAUFER D. B, (1996). Protein Sci. 5: 517-523.
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3.1.4 TRITON X-100
3.1.4.1 Introduction
The first step for a successful protein renaturation is to prevent aggregation through de- 
tangling of the mis-folded or aggregated particles. Detergents (section 1.4.7.3) were 
formerly used in protein biochemistry mainly for the solubilisation and extraction of 
membrane proteins during purification. However, a report by Zardeneta and Horowitz 
(1994) has reviewed the efficacy of non-ionic detergents like Tween 20, Triton X-100 
and Octylglucoside in assisting the refolding of rhodanese. Triton X-100 is a mild non­
ionic detergent and is the member of the Triton family that is extensively used for its 
efficiency in membrane solubilisation and is less costly than any other detergent from 
the same family (Slinde and Flatmark, 1976). In the present series of studies, Triton X- 
1 0 0  as a possible refolding assistant is investigated for its expected role in preventing or 
inhibiting the aggregation process with consequent yield improvements. Aggregation at 
high protein concentrations was shown to be a problem in the previous dilution 
experiments section. Wetlaufer and Xie (1996) determined a suitable concentration of 
Triton X-100 (ca.10 mM) that completely inhibited the aggregation and improved the 
refolding yield of carbonic anhydrase. The plan of the present study allowed for the 
exploration of all the previously mentioned aspects.
3.1.4.2 Methods
The general method (refer to section 2.4.5) indicated that the initial guanidine 
hydrochloride concentration is 0.27 M at the start of the refolding period and also the 
periods of ice incubation and the standing on bench incubation. In the following part, 
two experimental designs were planned using Triton X-100 at a concentration of 0.5 % 
(v/v) as a potential refolding aid (Figure 2.2).
The first was to investigate the role of Triton X-100 on the refolding and binding stages 
using 0.5 M Gnd-HCl concentration. This experiment was planned as: a) the effect of 
TritonX-100 added on the start of the refolding process, b) after 2 hours of ice 
incubation, and c) before the binding to chromatography columns (i.e. after 2  hours of 
ice incubation, 1 hour standing on bench incubation, and then spinning).
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The second study investigated the way in which Con A refolds and the time relationship 
associated with the refolding process. Therefore, the experimental design was additions 
of Triton X-100 (a) using 0.5 M Gnd-HCl concentration at: 0 hour, 1/2 hour on ice, 1 
hour on ice, 2 hours on ice, 4 hours (2 hours on ice then 2 hours standing on bench 
incubation), (b) Using 0.27 M Gnd-HCl concentration (for comparison reasons between 
Gnd-HCl concentrations), Triton X-100 was added at: 0 hour, 1 hour on ice, and 2 hours 
(1 hour on ice then 1 hour standing on bench temperature incubation). In addition, an 
extreme experiment using 0.5M Gnd-HCl concentration (all night on ice incubation and 
all day on bench incubation) was used to explore further the time-dependence of the 
refolding. Control sets are always maintained at the general refolding conditions with no 
addition of Triton X-100 and in this study designed using either 0.27 M or 0.5 M Gnd- 
HCl concentrations. The quality of the protein produced is represented by high 
A280/A260 ratios.
3.1.4.3 Results and Discussion
In this series of experiments, Triton X-100 at a concentration of 0.5% (v/v) was 
investigated during the refolding and binding stages at a final Gnd-HCl concentration of 
0.5 M (Table 3. 7). The first experiment (a) Triton X-100 addition at the start of the 
refolding period indicated zero yields compared to the control during the refolding 
stage. The second experiment (b) Triton X-100 addition after 2 hours ice incubation 
indicated a decrease of 51.61% in the yield compared to the controls. The third 
experiment (c) investigated the effect of Triton X-100 added at the binding stage (2 
hours ice incubation, 1 hour standing on bench incubation, and then spinning followed 
by detergent addition before column loading) and reported only a small decrease of 
7.63% in the yield compared to the control. Visual observations of clear solutions with 
no turbidity indicated that Triton X-100 appears to stop completely the aggregation 
process. This detergent reduces the association between the refolding intermediates to 
prevent correct folding (as well as aggregation) and this explains the zero yields 
obtained in the present study. Other workers who have used Triton X-100 to suppress 
aggregation have afterwards removed the detergent using compounds like cyclodextrin 
(Rozema and Gellman, 1996) before continuing with the next stages of purification. In 
the present work, because the effect of Triton X-100 on binding of Con A to the dextran
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affinity matrix was relatively small (7.63 % decrease in yield), it was decided not to 
attempt removal in subsequent folding experiments.
A further study was conducted focusing on the timings of Triton X-100 additions (Table 
3.8), to explore more deeply the refolding process concerning current ideas on Con A 
folding. The study investigated the refolding process under different conditions while 
using 0.27 and 0.5M Gnd-HCl final concentrations. (The resultant purified yields are of 
high quality especially when using 0.5M Gnd-HCL and this can be seen from 
(A280/A260) ratios.) The design of the experiments was planned to focus on the time- 
course of the refolding progress because results from the first study (Table 3.7) 
suggested that Triton X-100 could be used as a “tool” to stop folding completely at set 
intervals. Because it has been shown that there is then little effect of detergent on 
binding of already folded Con A to dextran, this allows measurements to be made of 
how much folding has taken place up to the moment of detergent addition.
The first set of experiments (a), using 0.5M Gnd-HCL final concentration and detergent 
addition at: 0 hour showed a 100% decrease relative to the control, at V2 an hour 
refolding on ice, indicated a vast decrease of 86.01%, at 1 hour on ice indicated a 
decrease of 74.09% , and at 2 hours on ice showed a decrease of 55.51%.. Triton X- 
100 addition at 4 hours (2 hours on ice, 2 hours on bench) indicated a decrease of 
24.21% relative to the control, (b) The second set of experiments, using 0.27M Gnd- 
HCL final concentration and detergent addition at: 0 hour indicated 100% decrease 
relative to control, at 1 hour refolding on ice indicated a decrease of 45.96%, at 2 hours 
refolding (1 hour on ice, 1 hour on bench) indicated the same yield as the control i.e. 
0% decrease. These experiments using 0.5M Gnd-HCl, (Table 3.8 (a), and Figure3.21) 
indicated a slower pace of folding compared to 0.27M Gnd-HCl (Table 3.8 (b), and 
Figure 3.22). However, fewer data points were obtained for the latter conditions.
An experiment (Table3.8 (a), and Figure 3.21) using “extreme” time periods was 
conducted to assess the time limits during the refolding process. This experiment was 
all night ice incubation and then all day standing at bench temperature and indicated a 
decrease of 13.92% compared to the control. This “extreme” experiment has shown that 
there are limits for the refolding process to occur and that after longer time at 0°C 
aggregation may still reduce the overall yields.
The most important findings are shown by a time-course plot of the more extensive data 
set (Figure 3.23), which showed a nearly constant rate of increase in the refolding yield 
obtained. On further investigation, this approach might give insights into the kinetics of
105
folding. It is significant that Chatterjee and Mandal (2005) have studied the quaternary 
association and reactivation of dimeric Con A (Figure 3.24) by refolding pure plant- 
derived lectin at pH 5.2, where the dimer rather than tetramer predominates. Their 
experiments show a low level of activity of the refolding protein up to 80 minutes 
followed by a faster rate of folding up to 200 minutes. It is striking that although 
recombinant Con A has been refolded here (Figure 3.23) under different conditions, 
nevertheless similar times are taken to recover similar levels of activity. Why the 
recombinant protein shows no lag in folding is not clear, but may be due to a number of 
factors: the 4.5-fold higher Con A protein concentration, the higher pH = 7.0 (which 
favours tetramer formation after dimerisation), lower temperature for most of the 
experiment, different buffer composition, or other factors.
An important correlation was found by Chatterjee and Mandal (2005) between regain of 
activity on refolding (Figure 3.24) and re-association of subunits to form dimers, which 
was determined in a separate experiment. That these two processes run in parallel 
strongly suggests that dimer formation is an essential early step in successful folding. 
The findings in the present work on refolding of this recombinant lectin are therefore in 
broad agreement with those of other workers on the plant-derived protein.
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Timing o f  Triton X-100  
Additions
Refolding Yield 
0.5 M Gnd-H 
Cl
Binding Yield 
0.5 M Gnd-HCl
(mg/1
culture)
A 280/A 260 Relative 
Yield %
(mg/1
culture)
A 280/A 260 Relative 
Yield %
Control
(No addition o f  Triton X-100)
23.3
26.7
M =24.9
2.0
1.9
100 23.1
26.7
M -2 4 .9
2.0
1.9
100
(a)TritonX-lOO 
Addition at the start
0.0 ---- 0.0 -----
(b)TritonX-lOO addition after 2 
hours ice incubation
12.1 4.5 48.6
(c)TritonX-lOO addition before 
binding to chromatography 
columns (2hours on ice, 1 hour 
on bench, then spin, then add 
Triton X-100)
23.9
22.1
M=23
1.823
1.784
92.4
Table 3.7 Effect of the timings of Triton X-100 additions on the refolding and binding of Con A 
(At 0.5 M Gnd-HCl concentration)
Control sets with no additions o f  Triton X-100, lhour ice incubation and lhour standing on bench. 
Refolding variables were the addition o f  Triton X -100 (a) at the start, (b) after 2 hours ice incubation, and 
(c) after 1 hour standing on bench incubation. Binding conditions were the additions before binding to 
columns i.e. after 2 hours ice incubation, 1 hour standing on bench incubation, and then spinning. Table 
shows relative percentage yields compared to controls.
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Refolding conditions Timings o f  
Triton X-100  
Additions
Yield (mg/1 
culture)
(A280/A 260) Relative Yield
%
(a)
Refolding 
0.5M  Gnd-HCl 
3 hours:
2 hours on ice,
1 hour on bench
Control
(No addition o f  Triton X- 
100)
37.4
29.1
M =33.2
4.2
3.1
100
0 hour
0.0 - 0.0
Vi hour 
On ice 4.7 1.8 14.2
1 hour 
On ice 8.6 4.9 26.0
2 hours 
On ice
16.3
13.3 
M =14.8
4.6 44.6
Refolding 
0.5M  Gnd-HCl 
4 hours:
2 hours on ice,
2 hour on bench 
Incubation
4 hours:
2hours on ice,
2 hours on bench
25.2 1.8 75.9
Refolding 
0.5M  Gnd-HCl 
(extreme):
All night on ice, 
A ll day on bench 
incubation
Extreme:
All night on ice, 
A ll day on bench
28.6 2.8 86.1
(b)
Refolding 
0.27M  Gnd-HCl 
2 hours:
1 hour on ice,
1 hour on bench 
Incubation
Control
(No addition o f  Triton X- 
100)
22.3 2.2 100
0 hour 
On ice 0.0 _ 0.0
1 hour 
On ice 12.1 2.0 54.3
2 hours 
1 hour on ice,
1 hour on bench
22.3 2.0 100
Table 3.8 Effect of the timing of Triton X-100 additions on the refolding of Con A 
(At 0.5 and 0.27M Gnd-HCl Concentrations)
Shows the use o f  Triton X -100 as a tool to investigate time-course o f  refolding at 0.27 and 0.5 M Gnd- 
HCl final concentrations. Control sets are the refolding conditions with no additions o f  Triton X-100. 
Table indicates the high yield obtained at the control level when refolding at 0.5M and also during the 2 
hours ice incubation period. Furthermore, the Table also indicates clearly the nearly double amount o f  the 
yield when doubling the time at which Triton X -100 was added.
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Figure 3.21 Effect o f timings o f TritonX-100 additions on the relative yields o f Con A 
(when refolding at 0.5 M Gnd-HCl concentration)
Shows the relationship between the timings o f additions o f Triton X-100 and the relative yields. Control 
sets are the refolding conditions with no additions o f TritonX-100. Figure indicates the increase o f 
refolding yields with the increase in time. Figure used data from Table 3.8, part (a).
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Figure 3.22 Effect o f timings o f TritonX-100 additions on the relative yields o f Con A 
(when refolding at 0.27 M Gnd-HCl concentration)
Relates the yields to the tim ings o f  TritonX-100 additions at 0.27 M Gnd-HCl concentration. Control sets 
are the refolding conditions with no additions o f  TritonX-100. Refolded yields increased with increasing 
time in the absence o f  detergent.
Figure used data from Table 3.8, part (b).
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Figure 3.23 Time-course of folding of Con A
Shows the variation in relative yield with the time o f  the addition o f  Triton X-100. Detergent was added 
at time intervals o f  0, 30, 60, 120, and 240 minutes. Yield is shown relative to the Control {33.2 mg/1 
obtained after refolding (without Triton X -100 addition) over 3 hours: 2 hours ice incubation, and then 1 
hour standing on bench, as in Table 3.8. The concentration o f  Con A available for refolding is estimated 
from the control yield as 92 fig/ml or 3.6 pM (with respect to monomer).}. Figure indicates the time- 
course o f  the refolding process for recombinant Con A  at pH 7.0 (in a crude mixture o f  bacterial inclusion 
body material) and shows how with time the refolding yields steadily increase. Based on data from Table 
3.8, part (a).
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Figure 3.24 A  plot o f percent reactivation against tim e for pure plant Con A
Shows a plot o f  percent reactivation against time for pure plant Con A refolding at pH 5.2 as determined 
by a combination o f  affinity technique and OPA fluorescent method o f  protein estimation. The data are 
shown for a protein concentration o f  0.8 pM and a constant temperature o f  25 °C throughout. Reproduced 
from Chatterjee, A ., M andal D .K., (2005). International Journal o f  Biological Macromolecules 35: 
103-109.
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Chapter Four
General Discussion and Conclusion
4.1 Introduction
The current project tried to optimise the refolding conditions of recombinant Con A by 
preventing or reducing the aggregation process without detriment to the folding 
processes producing active soluble lectin. The five different studies conducted as part of 
the project found that aggregation is a major cause of poor refolding yields that are the 
main barrier encountered during refolding in industrial settings.
4.2 Glycerol
The study investigated the effect of different glycerol concentrations on the refolding 
and binding stages of Con A. Results revealed that glycerol not only negatively affects 
the over all renaturation yields but also has a greater impact on the binding behaviour of 
the lectin towards the dextran (Table 3.1 and Figure 3.3). This result is consistent with a 
study conducted by Lopez-Jaramillo, et al., (2004) who observed that glycerol can 
occupy the saccharide binding sites in Con A crystals (Figure 3.6). This provides an 
explanation for the interference of glycerol with binding of Con A to the dextran affinity 
matrix observed here. Glycerol is widely celebrated as a refolding assistant with other 
proteins Meng, et al., (2001). However, the current study excludes its effects on the 
refolding of Con A as proteins differ in their actions towards different refolding 
conditions. Therefore, as a conclusion, it is assumed that glycerol competes with 
dextran for the carbohydrate-binding site of Con A so reducing recovery yields. 
However, glycerol is not very effective in eluting Con A which has already bound to 
dextran in its absence, compared with elution by methyl-oc-D-mannopyranoside (the 
saccharide normally used for specific elution). Glycerol was not investigated further as 
a folding aid for Con A due to these specific binding problems reducing recovery from 
the affinity columns.
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4.3 Guanidine Hydrochloride (Gnd-HCI)
The study explored the effect of different low concentrations of guanidine 
hydrochloride on the refolding and binding of Con A as reported in literature (refer to 
section 1.4.7.1). The present study ruled out the use of concentrations of 0.75 to 1.5M as 
unsuitable since their effect on the binding and refolding of Con A produced an obvious 
decrease on the renaturation yields (Table 3.2, Figures 3.8 and 3.9). Moreover, the 
comparison between the 0.27 and 0.5 M Gnd-HCI concentrations (Table 3.2) during the 
phases of refolding and binding indicated the more positive effect of 0.5 M 
concentration on the refolding of Con A than 0.27M. Although, 0.27 M Gnd-HCI 
produces acceptable refolding yields, 0.5 M Gnd-HCI concentration appeared to 
improve the overall yields. The use of Gnd-HCL at 8 M completely unfolds Con A, 
while diluting to 0.27 M allows for its refolding. Raising the concentration to 0.5M 
allows for more refolding since it can prevent aggregation to some extent. This may be 
through the denaturant increasing the solubility of a hypothetical unstable monomer. A 
review by De Bemardez Clark (2001) pointed out that, although low Gnd-HCI 
concentration prevent aggregation the use of concentrations less than 0.25 M inhibited 
the dimerization of the platelet-derived growth factor (PDGF). The present findings 
have opened a new door to obtain higher refolding yields by adopting the 0.5M final 
Gnd-HCI concentration during refolding in further studies.
4.4 Dilution
The third study investigated the role played by different dilution protocols on the 
production of biologically active Con A. In this study rapid, continuous, pulse and step­
wise dilution are explored. The first part exploited different dilution factors of the rapid 
protocol to see their effect combined with 0.27 and 0.5 M Gnd-HCI on the refolding 
yield (Table 3.3). The dilution factor 30X indicated the maximum yield obtained using 
0.5 M Gnd-HCI concentration. Further, the different protocols were compared to 
controls (Table 3.4 and Figure 3.12) where the continuous dilution protocol has shown 
the best yield by a small margin obtained when using the 0.5 M Gnd-HCI concentration 
compared with the other protocols. However, manual continuous dilution is much more 
laborious in practice than rapid dilution. The small margin of improvement did not
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justify further work to automate continuous dilution using pumped systems. The study 
has also shown that step-wise dilution is an un-desirable method for the refolding of 
Con A as it reduces the overall yields by the forming large amounts of aggregates. 
Moreover, the study relates dilution 3OX (protein concentration) with Gnd-HCI 
concentration (0.5 M), identified as appropriate from the previous study, as suitable 
factors in producing optimum yields when combined together. This work initiated 
examination of the relationship between the protein concentration and the renaturation 
yield (Figure 3.16). It is seen that high protein concentration gives rise to aggregation, 
while lowering the protein concentration produces increasing yields. However, when 
protein concentration is lowered further the yields decrease again. This observation is 
explained by a hypothetical scheme (Figure 3.15) indicating the formation of a fully 
folded dimer through the formation of a partially folded monomer. Two possible 
pathways are depicted: Association 1 is less sensitive to dilution as stable monomer 
exists with unlimited time available to find a partner and proceed to form a fully folded 
dimer and complete the folding process. {This is represented by the expected line in 
(Figure 3.16).} Association 2, where unstable partially folded monomer exists, is more 
sensitive to dilution with a limited time to fold. This unstable partially folded monomer 
might follow different pathways: either aggregating at high protein concentrations, or 
forming an inactive soluble monomer, or succeeding in following the Association2 
pathway to find a partner and form a partially folded dimer. {This represented by the 
actual line in (Figure 3.16).} These hypotheses are in agreement with the general 
principles reviewed by Price (1994) when considering the re-folding of multi-subunit 
proteins. High protein concentration favours aggregation that is produced by non­
specific hydrophobic surfaces exposed early in the refolding pathway. Low enough 
concentrations of protein cause the rate of association reactions to become so slow that 
non-associated species will exist for significant periods of time. These intermediates are 
of limited stability so may be degraded by proteases, chemically modified or adsorbed 
onto surfaces such as the walls of the reaction flask. This explains why the yield of 
active multi-meric protein declines at low concentrations. As protein concentration is 
varied, these competing trends of aggregation versus “correct” folding/association give 
rise to curves showing a maximum yield of active protein at an optimum concentration. 
An example of such a curve of concentration versus reactivation by Rudolph et al. 
(1977) is shown in (Figure 4.1) and shows a maximum. This resembles the plot given 
earlier (Figure 3.16) and indicates that the fate of an unstable intennediate is critical for
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correct folding. To conclude, this dilution study is very important in understanding the 
pathway followed by Con A to ensure correct refolding. Experimentally determined 
limits to dilution enable optimised refolding yields.
4.5 Temperature
The study concerned the effect of different incubation temperatures on refolding 
through tackling the aggregation process. Usually lower temperatures reduce 
aggregation since hydrophobic interactions are weakened. Temperature is of vital 
importance and optimising it might lead to further improvement of renaturation yields. 
Table (3.6a), indicated that a very low temperature (- 5.5 °C) does not aid the refolding 
process and that at very high temperatures aggregation occurs with no detectable yields. 
Although continuous incubation at 0°C produced the highest yields, problems with 
column blockages were a disadvantage of refolding at this temperature. In contrast to 
this, a gradual warming up step produced some improvement in yield especially when 
incubating initially at 0°C. The study agrees with Yoshii et al. (2000) in that low 
temperatures have a definite role in the prevention of hydrophobic aggregation where an 
improvement of yield occurred. The results are also in agreement with the techniques of 
Wetlaufer and Xie (1996). Moreover, this study initiated use of a 2 hour ice incubation 
for the first time in our laboratory and this proved to be an important development in 
achieving greater yields since it allowed more time for the refolding process to 
complete. The gradual warming up step after a longer incubation on ice is another 
achievement that improved the overall yield. So to conclude, this was a good step 
towards optimising the refolding process and therefore was incorporated in the 
subsequent study.
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Figure 4.1 The regain of activity of lactate dehydrogenase (H4 isoenzyme)
Shows the after denaturation o f  lactate dehydrogenase (H4 isoenzyme) as a function o f  protein 
concentration. A number o f  different methods o f  denaturation (low  pH, Gdn-HCl, urea) were used in 
these experiments. Reproduced from (Rudolph et al., 1977). Biochemistry, 16: 3384.
118
4.6 TRITON X-100
The fifth study explored different aspects of Triton X-100, a non-ionic detergent that is 
extensively used in the washing and solubilisation of inclusion bodies. The effect of 
Triton X-100 was first investigated on the refolding and binding of Con A (Table 3.7), 
where a zero yield was obtained at the refolding stage but only a small decrease was 
found in binding. This distinct result indicated that Triton X-100 interacts with the 
refolding intermediates at an early stage of the refolding process while at the same time 
its effect on binding to the dextran is very limited. These findings were developed into 
the idea of using Triton X-100 as a method to explore further the refolding process 
through the adoption of certain timings of Triton X-100 additions to the refolding 
mixtures, knowing that no effect will occur on the binding to the dextran stage. 
Different timings were selected, Gnd-HCI concentrations of 0.27 and 0.5 M, different 
incubation periods on ice and on bench, and all with the 3 OX factor of the rapid dilution 
protocol (relating the previous studies with the current one).
A plot of the relative yield versus time (Figure 3.23) resulted from this study and 
indicated the progress of the refolding process. This agreed to some extent with a plot 
by Chatterjee and Mandal (2005) (Figure 3.24). Moreover, their study also related to the 
quaternary association and reactivation of dimeric Con A. Furthermore, these findings 
were in accordance with the hypothetical Association 2 pathway (Figure 3.15) and the 
actual plot (Figure 3.16) shown earlier in the dilution study. This novel demonstration 
of the great sensitivity of Con A folding to inhibition by Triton X-100 shows that an 
essential step on the correct folding pathway depends on hydrophobic interactions 
taking place. It seems likely that these interactions are between hydrophobic surfaces 
essential for association of the subunits so that they can form dimers and complete their 
folding. Detergent inhibition of folding is an easy and inexpensive method which can be 
developed to investigate further aspects of the refolding of proteins. Furthermore, 
detailed experiments are required and the use of purified proteins with accurately known 
concentration values is desirable in this novel technique.
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4.7 Conclusions
As reviewed in the Introduction (Section 1.3), aggregation is the major problem facing 
large scale production and maximum yield. Aggregation occurs when intra- and 
intermolecular interactions driving protein folding are not correctly balanced during the 
renaturation or refolding process. Major sources of aggregation are: hydrophobic 
interactions, unfavourable apolar-polar interactions, high protein concentration, high 
concentrations of refolding intermediates, and non-specific aggregation.
The current project tried to avoid aggregation and improve the overall protein yield 
where it identified glycerol as an unsuitable aid in the refolding of Con A due to the 
binding effect it possessed towards the affinity dextran. Further results recommended 
the use of 0.5 M Gnd-HCI concentration as the initial point that guarantees increased 
refolding yields. The rapid and continuous dilution protocols are more suitable than the 
other exploited refolding techniques used in this project in improving the refolding 
yields of Con A. However, rapid dilution is still the preferable method to use since it is 
simple and reproducible. The 3OX dilution factor has been demonstrated to be the 
optimum to enhance the refolding yields. A gradual warm-up step ensured the recovery 
of most of the refolded Con A and a 0°C temperature incubation combined with this 
technique improved the overall yield to maximum levels. Lengthening the ice 
incubation period to 2  hours instead of 1 hour allowed for more yield to be recovered. 
Triton X-100 does not aid the refolding of Con A due to its inhibitory effects on 
essential hydrophobic associations. However, its use as a tool is considered a 
breakthrough for estimating the time-course of refolding of the lectin, providing that 
more detailed experiments are conducted to improve the method. The combined 
findings allowed for development of a hypothetical scheme (Figure 3.15) to help 
understand the refolding pathway of Con A.
The major findings for increasing yield in this work can all be explained by their effects 
of decreasing the likelihood of aggregation of partially-folded intermediate forms of 
Con A. This is in general agreement with the ideas widely reported for other proteins 
and reviewed in the literature (as explained in the Introduction). In addition, Triton X- 
1 0 0  was found to suppress desired folding interactions in addition to any unwanted 
aggregation, so that the yield of active Con A was reduced to zero in its presence. 
However, this initially disappointing result became an unexpected bonus when it was 
shown that Triton X-100 could be used to investigate the time course of Con A folding.
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Because this detergent was shown not to interfere with dextran binding by already 
folded lectin, it could be used to stop further folding occurring in a mixture, so that the 
amount of already folded protein could be easily measured at any desired time point. 
These experiments demonstrated that the time course of refolding determined in the 
present work for recombinant Con A was in accord with that for native Con A from jack 
beans (Section 3.1.4.3 and Section 4.4). The effects of Triton X-100 point to the 
importance of hydrophobic interactions at subunit interfaces which are essential for 
assembly of dimers of biologically active Con A.
My combined strategy improved the renaturation yield from only 12 mg/1 culture to 33 
mg/1 culture i.e. a 2.75-fold increase. Other studies (Dong et al., 2007; Wang et al., 
2008) following different dilution protocols have also reported an improvement in their 
final yields, however, these enhancements were not as high as I achieved in this project. 
New general protocols have been developed for the refolding of proteins. The REFOLD 
(2005) database ( http://refold.med.monash.edu.au ) provides over 200 new protocols 
for overexpression, solubilisation and refolding of recombinant proteins. Today, protein 
refolding screening kits are available on the market: ( www.moleculardimensions.com ) 
and also the iFOLD protein refolding system from Novagen ( www.novagen.com/ifold 
). These are designed to ensure accuracy and facilitate the tedious and time consuming 
refolding process, while minimising the budget needed for large volumes of buffers and 
refolding vessels.
Finally, from what has been achieved in this project, a wider approach to refolding can 
be followed in future studies utilising the continuous dilution protocol with an 
automated device that can control the volume of the denatured material added at an 
appropriate rate to refolding buffers. By using a stirred thermostated vessel temperature 
ranges can be changed as required. This would be advantageous for scaling up the 
process for industrial applications.
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